Tissue Doppler Imaging in the Estimation of Intracardiac Filling Pressure in Decompensated Patients With Advanced Systolic Heart Failure
Summary: The ratio of early transmitral velocity to tissue Doppler mitral annular early diastolic velocity (E/Ea) has been correlated with pulmonary capillary wedge pressure in a wide variety of cardiac conditions. However, the reliability of the mitral E/Ea ratio for predicting pulmonary capillary wedge pressure in patients admitted for advanced decompensated heart failure is unknown. A total of 106 prospective consecutive patients with advanced decompensated heart failure (ejection fraction Յ30%, New Your Heart Association class III to IV symptoms) underwent simultaneous echocardiographic and hemodynamic evaluation on admission and after 48 hours of intensive medical therapy. We found the predictive value of baseline mitral E/Ea ratio in estimating pulmonary capillary wedge pressure to be less robust than previously reported, which appears to be related to larger left ventricular dimensions, more impaired cardiac output, and the presence of cardiac resynchronization therapy. In addition, no reliable direct correlation between baseline or changes in mitral E/Ea ratio and pulmonary capillary wedge pressure was found. Taken together, our observations provide an important refinement in the clinical interpretation of the mitral E/Ea ratio as it applies to patient populations in which important confounders such as alterations in myocardial structure, severity of systolic dysfunction, or the presence of synchronized pacing may pose challenges to the accurate prediction of left ventricular filling pressures.
Conclusion: In decompensated patients with advanced systolic heart failure, tissue Doppler-derived mitral E/Ea ratio may not be as reliable in predicting intracardiac filling pressures, particularly in those with larger left ventricular volumes, more impaired cardiac indices, and the presence of cardiac resynchronization therapy. 2
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation
Summary: Catheter ablation has become an increasingly popular and acceptable treatment option for the atrial fibrillation patient. Nevertheless, many questions remain about preprocedural predictors of ablation failure. Here, we describe a novel delayed-enhancement MRI-based method to detect and quantify preexistent left atrial structural remodeling in patients undergoing ablation of atrial fibrillation. We found that patients with extensive preablation left atrial enhancement were more likely to suffer atrial fibrillation recurrence after ablation than those with minimal or moderate degrees of enhancement. This noninvasive modality would allow patients to be selectively screened before ablation to determine whether they are appropriate candidates for the procedure. The ability to properly select ablation patients will reduce the unnecessary risks and costs to those patients who stand to benefit little from the procedure.
Conclusions: DE-MRI provides a noninvasive means of assessing left atrial myocardial tissue in patients suffering from atrial fibrillation (AF) and might provide insight into the progress of the disease. Preablation DE-MRI holds promise for predicting responders to AF ablation and may provide a metric of overall disease progression. 3 
Rheumatic Heart Disease Screening by Echocardiography: The Inadequacy of World Health Organization Criteria for Optimizing the Diagnosis of Subclinical Disease
Summary: It has recently been estimated that Ͼ200 000 patients die from rheumatic heart disease (RHD) every year worldwide, with most of these cases occurring in developing nations. RHD usually results from the cumulative cardiac damage from recurrent episodes of acute rheumatic fever. After a first attack, penicillin therapy has been shown to be effective in reducing the risk of evolution for more severe lesions. Accordingly, identifying children with early signs of RHD is a crucial issue. In this setting, echocardiography has been shown to be an efficient tool to detect subclinical rheumatic valve features in school-aged children. In the present article, we have found that focusing on morphological criteria of valve changes, rather than echo-Doppler criteria, has a major impact on the number of detected cases and that the diagnostic criteria proposed by the World Health Organization Expert Committee in 2001 may be relatively insensitive for early RHD case detection. Because the boundary between physiological valve regurgitation and authentic but minimal rheumatic lesions remains difficult to discern in some cases and because no gold standard exists for RHD, the challenge now is to define/recommend optimal criteria that may be easily used worldwide and allow accurate detection of the largest number of children who might benefit from early preventive efforts.
Conclusions: Important consideration should be given to echocardiographic criteria for detecting subclinical RHD because the number of cases detected may differ importantly according to the diagnostic criteria utilized. Currently recommended WHO criteria risk missing up to three quarters of cases of subclinically affected and therefore potentially treatable children with RHD. 4
Left Atrial Function in Diastolic Heart Failure
Summary: The underlying pathophysiological mechanisms for the transition from an asymptomatic state of diastolic dysfunction to one of diastolic heart failure (DHF) are poorly defined. A noninvasive index that can help identify patients with DHF from those with asymptomatic diastolic dysfunction is of clinical interest. This study compared several parameters of left atrial (LA) and left ventricular function and arterial elastance between patients with DHF and diastolic dysfunction. Left ventricular volumes, mass, and systolic function were not significantly different between the 2 groups. Likewise, LA volumes and noninvasive measurements of LA systolic function, as well as arterial elastance were similar in patients with DHF and those in the diastolic dysfunction group. On the other hand, LA systolic strain was significantly lower in patients with DHF, and LA stiffness, both by invasive and noninvasive estimates, was significantly higher. LA stiffness was strongly correlated to the pulmonary artery systolic pressure and was the most accurate parameter in differentiating patients with DHF from diastolic dysfunction.
Conclusions: Patients with DHF have increased LV mass and LA volume in comparison with normal controls, but not versus patients with LV hypertrophy who are not in heart failure. On the other hand, LAS strain is significantly reduced and LA stiffness is the most accurate index in identifying patients with DHF. 5
Adenosine Stress 64-and 256-Row Detector Computed Tomography Angiography and Perfusion Imaging: A Pilot Study Evaluating the Transmural Extent of Perfusion Abnormalities to Predict Atherosclerosis Causing Myocardial Ischemia
Summary: Multidetector computed tomography coronary angiography (CTA) is a robust method for the noninvasive diagnosis of coronary artery disease. However, in its current form, CTA is limited in its prediction of myocardial ischemia. This pilot study investigated whether the combination for CTA and adenosine stress CT myocardial perfusion imaging can accurately detect atherosclerosis, causing perfusion abnormalities compared with the combination of invasive angiography and single-photon emission computed tomography. In a quantitative analysis, CT perfusion images were analyzed for the transmural perfusion ratio, the ratio of the subendocardial attenuation density, and the subepicardial attenuation density. This study demonstrated that CT perfusion imaging, when performed with adenosine, can detect subendocardial perfusion deficits and the combination of CTA and CT perfusion imaging can detect obstructive atherosclerosis causing perfusion abnormalities when compared with the combined gold standard of invasive angiography and singlephoton emission computed tomography myocardial perfusion imaging. If confirmed by larger studies, the combination of CTA with CT perfusion imaging could have important implications to the future diagnostic evaluation of patients with suspected coronary artery disease.
Conclusions: The combination of CTA and CTP can detect atherosclerosis causing perfusion abnormalities when compared with the combination of quantitative coronary angiography and SPECT. 6 
Noninvasive Coronary Angiography by 320-Row Computed Tomography With Lower Radiation Exposure and Maintained Diagnostic Accuracy: Comparison of Results With Cardiac Catheterization in a Head-to-Head Pilot Investigation
Summary: Our head-to-head comparison of whole-heart 320-row computed tomography (CT) and conventional coronary angiography has important clinical implications because it shows that 320-row coronary CT angiography has high diagnostic accuracy for detection of coronary artery stenoses, whereas radiation exposure (determined as "effective dose in mSv") is significantly lower (4.2 versus 8.5 mSv) than that of conventional coronary angiography. Because noninvasive coronary CT angiography would be best applied as a rule-out test to all persons with low to intermediate pretest likelihood of coronary artery disease to avoid unnecessary conventional coronary angiography and thereby reduce complications and risks, it is of tremendous importance to reduce the previously high burden of ionizing radiation of coronary CT angiography. Using whole-heart data prospectively acquired with 320-row CT greatly reduces exposure because it avoids radiation-intensive overscanning and overranging. Moreover, it also increases image quality and results in good diagnostic performance because data are typically acquired in a fraction of a second (0.45-0.6 second) during a single heartbeat (if heart rate is Ͻ65 bpm). Thus, the entire 3-dimensional data set is temporally uniform and not constructed from multiple consecutive heartbeats as with scanners not covering the entire heart in a snapshot (because of fewer detector rows), thereby reducing heart rate-and breathing-related motion artifacts. Finally, this whole-heart approach has the long-term clinical potential to develop 4-dimensional acquisition strategies for additional analysis of myocardial perfusion with the use of 320-row CT. Such an approach might enable comprehensive evaluation of a range of patients with known or suspected coronary artery disease.
Conclusions: CT with the use of emerging technology has the potential to significantly reduce the radiation dose and amount of contrast agent required compared with conventional coronary angiography while maintaining high diagnostic accuracy. 7
Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus
Summary: Cardiac disease is the leading cause of mortality in type 2 diabetes mellitus. The blood glucose-lowering thiazolidinedione pioglitazone has been associated with improved cardiac outcome but also with an elevated risk of congestive heart failure. Use of metformin, at present the drug of choice in the treatment of type 2 diabetes mellitus, showed improved outcome in the United Kingdom Prospective Diabetes Study but has been related to adverse cardiac events in other studies. Using MRI and proton and phosphorus magnetic resonance spectroscopy, as well as [18F]-2-fluoro-2deoxy-D-glucose and [11C]palmitate positron emission tomography, this randomized, controlled, double-blinded study investigated the effects of 24-week treatment with pioglitazone or metformin on myocardial function and metabolism in men with well-controlled, uncomplicated type 2 diabetes mellitus who had no clinical evidence of myocardial ischemia. The major findings revealed that pioglitazone but not metformin improved left ventricular diastolic function and cardiac compliance. In addition, pioglitazone and metformin showed differential action on myocardial substrate metabolism; however, this did not translate into alterations in myocardial highenergy phosphate metabolism or myocardial triglyceride content. Both agents improved whole-body insulin sensitivity. None of the treatments were associated with clinically evident edema or congestive heart failure. These data suggest that for male patients with well controlled, uncomplicated type 2 diabetes mellitus without cardiac ischemia, treatment with pioglitazone may be a good safe option because it may favorably influence myocardial function.
Conclusions: In type 2 diabetes mellitus patients, pioglitazone was associated with improvement in some measures of left ventricular diastolic function, myocardial glucose uptake, and whole-body insulin sensitivity. The functional changes, however, were not associated with myocardial substrate and high-energy phosphate metabolism. 8 
Detection of Myocardial Damage in Patients With Sarcoidosis
Summary: In patients with sarcoidosis, sudden death is a leading cause of mortality, which may represent clinically unrecognized cardiac involvement. Delayed-enhancement cardiovascular magnetic resonance (DE-CMR) can detect very small amounts of myocardial damage; therefore, we sought to evaluate the usefulness of DE-CMR for identifying cardiac involvement in 81 consecutive patients with biopsy-proven extracardiac sarcoidosis. When compared with a standard clinical evaluation, which included 12-lead ECG and at least 1 dedicated non-CMR cardiac study (echocardiography, radionuclide scintigraphy, or cardiac catheterization), DE-CMR identified cardiac involvement at a Ͼ2-fold higher rate. Patients were also followed up for 21 months on average for major adverse events (death, defibrillator shock, or pacemaker requirement). During follow-up, patients with myocardial damage on DE-CMR had a 9-fold higher rate of adverse events and an 11.5-fold higher rate of cardiac death than patients without damage. On the basis of these findings, we believe that DE-CMR is more than twice as sensitive for cardiac involvement as currently used standard methods. Myocardial damage detected by DE-CMR also appears to be associated with future adverse events, including cardiac death, but events were few, and this needs confirmation in a larger cohort.
Conclusions:
In patients with sarcoidosis, DE-CMR is more than twice as sensitive for cardiac involvement as current consensus criteria. Myocardial damage detected by DE-CMR appears to be associated with future adverse events including cardiac death, but events were few, and this needs confirmation in a larger cohort. 9
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Summary: Aortic valve stenosis remains a diagnostic and therapeutic challenge, particularly in the elderly. In patients with aortic stenosis, left ventricular hypertrophy compensates for pressure overload. Left ventricular hypertrophy may be accompanied by interstitial myocardial fibrosis starting at the subendocardial layers and progressing toward replacement fibrosis. Importantly, fibrosis also may have an impact on patient outcome after aortic valve replacement. In a clinical follow-up study, we assessed the degree of myocardial fibrosis and its influence on myocardial function and clinical outcome after aortic valve replacement in patients with symptomatic severe aortic stenosis. The findings support a preoperative diagnostic approach that focuses on the structural abnormalities of the left ventricular myocardium. In this context, myocardial replacement fibrosis seems to be the critical abnormality that can be visualized directly with late-enhancement cardiac MRI in most of these patients. This type of fibrosis has a profound impact on the long-term clinical outcome but remains undetected by standard echocardiographic examination. However, the longitudinal displacement of the mitral ring can be measured reliably during standard echocardiography, captures the functional consequences of myocardial fibrosis, and predicts functional improvement after aortic valve replacement. Thus, the evaluation of mitral ring displacement also may prove valuable for routine preoperative risk assessment.
Conclusions:
Myocardial fibrosis is an important morphological substrate of postoperative clinical outcome in patients with severe aortic stenosis and was not reversible after aortic valve replacement over the 9 months of follow-up examined in this study. Because markers of longitudinal systolic function appear to indicate sensitively both the severity of myocardial fibrosis and the clinical outcome, they may prove valuable for preoperative risk assessment in patients with aortic stenosis. 10
Cardiac Dysfunction Assessed by Echocardiographic Tissue Doppler Imaging Is an Independent Predictor of Mortality in the General Population
Summary: Tissue Doppler imaging (TDI) is a relatively recent echocardiographic technique well suited for evaluation of longitudinal myocardial function, which is suspected to be initially affected in various cardiac diseases. Most modern echocardiographic equipment has the ability to perform TDI and its use only prolongs the examination by a couple of minutes. The present study shows that in the general population where the majority is free of significant systolic and diastolic dysfunction using conventional echocardiography, TDI is able to identify systolic and diastolic cardiac dysfunction associated with an increased risk of mortality. The prognostic value of TDI was found to be incremental to age, sex, heart rate, body mass index, hypertension, diabetes, ischemic heart disease, plasma proBNP, and conventional echocardiography. These findings introduce TDI as an integral part of the standard echocardiographic examination of low-risk subjects and suggest that TDI may have a possible role as a screening tool of the general population.
Conclusions:
In the general population, in which most are free of left ventricular systolic dysfunction and restrictive diastolic filling using conventional echocardiographic parameters, left ventricular dysfunction by TDI is a powerful and independent predictor of death, especially when systolic performance and diastolic performance are considered together, recognizing their interdependency and their complex relation to deteriorating cardiac function. 11 chronically increased LA pressure and/or volume. Because the prevalence of LA enlargement increases with age, it is critical to have accurate normative reference ranges for heart sizes to correctly predict cardiovascular risk in the elderly. At present, there is a dearth of such reference data in population-based samples and in women. Accordingly, we have evaluated parameters of LA size in 230 healthy men and women (mean age, 76Ϯ5 years) who were judged to be free of heart disease, hypertension, and diabetes. These subjects were a subset of the Cardiovascular Health Study, a prospective, community-based study of risk factors for cardiovascular disease conducted in 5888 elderly participants. We found that LA size is more strongly related to measures of body weight than to body height and developed a series of reference equations that predict what the normal LA dimensions and volumes should be, based on the subject's age, height, and weight. We have also created some nomograms that will enable clinicians to easily diagnose LA enlargement. We hope that these data can be used to help better determine what a normal LA size should be. An earlier diagnosis of LA enlargement might permit earlier preventive cardiology strategies in, for example, hypertensive disease.
Conclusions: These data provide normative reference values for left atrial size in healthy older women and men. The results should be useful for refining diagnostic criteria for left atrial dilation in the older population and may be relevant for cardiovascular risk stratification. 12
Incremental Prognostic Value of Coronary CT Angiography in Patients With Suspected Coronary Artery Disease
Summary: This study demonstrates that Multidetector CT coronary angiography (MDCTCA) provides independent and incremental prognostic information in patients with suspected coronary artery disease (CAD). The presence of CAD was associated with increased risk for hard cardiac events (Pϭ0.0001-0.0003), which was higher (8.09% person-year) in patients with significant coronary stenoses but was not negligible (3.89%) in subjects with nonobstructive disease. An excellent prognosis was noted in patients with normal coronary arteries on MDCTCA (annualized event rate of 0.88%). Together with the presence of CAD, another important independent predictor of events was the presence of mixed/noncalcified plaques, regardless of lesion severity (PϽ0.0001). According to these results, MDCT has been confirmed as an extremely accurate noninvasive tool in coronary artery evaluation, capable of providing information about 2 of the most significant independent predictors of hard cardiac events (the presence and severity of CAD and the composition of atherosclerotic plaques).
Conclusions: MDCTCA provides independent and incremental prognostic information as compared to baseline clinical risk factors and calcium scoring in patients with suspected CAD. 13
Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus: Prevalence and Association With Myocardial and Vascular Disease
Summary: In the past decade, the term left ventricular (LV) diastolic heart failure or heart failure with normal ejection fraction has been introduced. The symptoms of heart failure are believed to be caused by abnormalities in LV filling, which are frequently seen in patients with type 2 diabetes mellitus. Whether LV diastolic dysfunction in patients with type 2 diabetes mellitus is caused by an intrinsic myocardial disorder or related to vascular disease is, however, still controversial. Better understanding of this is imperative for implementation of therapeutic interventions to improve the prognosis of these patients. In the present study, patients with type 2 diabetes mellitus with no history of heart failure or coronary artery disease referred to a diabetes clinic for the first time (nϭ305) were studied. The present study demonstrated a low prevalence of LV systolic dysfunction (9%); however, the study confirmed a high prevalence of LV diastolic dysfunction (40%). Importantly, the study suggested a close association between the presence of moderate or severe LV diastolic dysfunction and abnormal myocardial perfusion on myocardial perfusion scintigraphy, whereas the association with vascular function was considerably less prominent. Thus, our findings support the hypothesis that moderate or severe LV diastolic dysfunction and left atrial dilation in the early phase of type 2 diabetes mellitus are closely associated with intrinsic LV ischemic dysfunction. However, such LV diastolic dysfunction and left atrial dilation are not closely related to vascular disease with arterial stiffening and abnormal ventriculo-arterial coupling.
Conclusions: Abnormal LV filling is closely associated with abnormal myocardial perfusion on myocardial perfusion scintigraphy, whereas the association of LV filling with vascular function is less prominent. 14
Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia
Summary: This is the first prospective multicenter study with Doppler stress echocardiography devoted to screening for exerciseand hypoxia-induced pulmonary hypertension in relatives of idiopathic or familial pulmonary arterial hypertension patients and to investigate the threshold of normal pulmonary artery pressures during exercise in a large collective of healthy control subjects. One main finding of this study is that relatives of patients with idiopathic or familial pulmonary arterial hypertension have a significantly higher frequency of a hypertensive tricuspid regurgitation velocity response to exercise and to prolonged hypoxia than control subjects. The highest proportion of subjects with hypertensive tricuspid regurgitation velocity response was found in relatives who shared a BMPR2 mutation with the index patients. The data in this study suggest that a hypertensive pulmonary artery pressure response to exercise and hypoxia is genetically determined with familial clustering. The clinical significance of hypertensive pulmonary artery pressure response to exercise and hypoxia, however, is currently unsettled. It may reflect a normal variation in pulmonary artery pressures without clinical significance, or it may be related to some limitation in exercise capability that is relevant only under stress conditions. However, it may also reflect a genetic trait associated with increased risk for the development of pulmonary hypertension or high-altitude pulmonary edema. Although great effort was necessary to standardize the echocardiographic examination and to obtain high-quality tricuspid regurgitation velocity profiles, the study showed that this screening approach is applicable in clinical settings. Follow-up assessments in relatives of idiopathic or familial pulmonary arterial hypertension patients may provide a basis to decide whether stress echocardiography is an appropriate tool for early diagnosis of pulmonary arterial hypertension.
Conclusions:
Pulmonary hypertensive response to exercise and hypoxia in idiopathic/familial pulmonary arterial hypertension (PAH) relatives appears as a genetic trait with familial clustering, being correlated to but not caused by a BMPR2 mutation. The suitability of this trait to predict manifest PAH development should be addressed in long-term follow-up studies. 15 occurrence of spontaneous ventricular arrhythmia in patients with previous myocardial infarction who were scheduled for implantable cardioverter-defibrillator (ICD) therapy. Ninety-one patients (age, 65Ϯ11 years) underwent cine MRI to evaluate left ventricular function and volumes and contrast-enhanced MRI for characterization of scar tissue (infarct gray zone as a measure of infarct tissue heterogeneity, infarct core, and total infarct size). Appropriate ICD therapy was documented in 18 patients (20%) during a median follow-up of 8.5 months (interquartile range, 2.1-20.3). Multivariable Cox proportional hazards analysis revealed that infarct gray zone was the strongest predictor of the occurrence of spontaneous ventricular arrhythmia with subsequent ICD therapy (hazard ratio, 1.49/10 g; CI, 1.01-2.20; x 2 ϭ4.0; Pϭ0.04). These data suggest that in patients with previous myocardial infarction, infarct tissue heterogeneity on contrast-enhanced MRI is a strong predictor of spontaneous ventricular arrhythmia with subsequent ICD therapy (as surrogate of sudden cardiac death) even after adjusting for other clinical and MRI variables, that is, total infarct size and left ventricular function and volumes.
Conclusions: Infarct tissue heterogeneity on contrast-enhanced MRI is the strongest predictor of spontaneous ventricular arrhythmia with subsequent ICD therapy (as surrogate of sudden cardiac death) among other clinical and MRI variables, that is, total infarct size and left ventricular function and volumes, in patients with previous myocardial infarction. 16 
Lack of Association Between Migraine Headache and Patent Foramen Ovale: Results of a Case-Control Study
Summary: There has been considerable debate on the possible association between migraine and patent foramen ovale (PFO). Some small observational studies in patients with stroke have suggested a pathophysiological relationship between these 2 common conditions. Recent randomized studies of PFO closure have not definitively answered the question of whether an association exists. No prior observational studies have been designed prospectively to assess whether a pathophysiological association between migraine and PFO in the absence of stroke truly exists, and any single randomized trial of a specific device may be limited in its ability to test this general association. We therefore designed and executed a large, prospective, case-control study using quantitative measures of migraine severity and core laboratory assessment of PFO with transthoracic echocardiogram and transcranial Doppler to test this association and found no association between migraine headaches and the presence of PFO. In addition, we found no association between the severity of a right-to-left shunt and migraine or the severity of migraine and the presence of PFO. This study provides strong evidence against a pathophysiological association between PFO and migraine and would indicate that investigation of migraine pathophysiology should focus more on other mechanisms to prevent migraine.
Conclusions:
We found no association between migraine headaches and the presence of PFO in this large case-control study. 17
Left Atrial Strain and Strain Rate in Patients With Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed-Enhancement MRI
Summary: The underlying substrate for atrial fibrillation (AF) is fibrosis, a marker of structural remodeling. AF leads to progressive structural and functional changes in the left atrium (LA). Delayedenhancement (DE) MRI has been shown to detect LA fibrosis. With vector velocity imaging, using speckle tracking technology, quantification of atrial strain throughout the cardiac cycle from gray-scale images is feasible. Strain is an indicator of LA compliance or reservoir function, which is impaired in AF caused by fibrosis.
Vector velocity imaging overcomes some of the limitations of Doppler-based strain measurements such as angle dependency and influence by loading conditions. In our study, we demonstrated an inverse relationship between LA fibrosis by DE-MRI and LA midlateral strain and strain rate by vector velocity imaging. This relationship was more prominent in patients with persistent compared with paroxysmal AF. Lateral wall strain can be reliably imaged and may be used as a surrogate of LA wall fibrosis by DE-MRI. Interestingly, LA fibrosis and strain were not related to common etiologies for AF such as patient age, hypertension, left ventricular filling pressure, or mitral regurgitation. Regardless of the underlying etiology or the duration of AF, the degree of atrial fibrosis was the main determinant of severity of arrhythmia in this cohort. Noninvasive imaging of LA fibrosis may be helpful in predicting the risk of developing AF, guiding therapeutic strategies, and predicting the outcomes in patients with AF. It may allow us to identify patients earlier in their disease process, before the development of severe or irreversible abnormalities.
Conclusions: LA wall fibrosis by delayed-enhancement MRI is inversely related to LA strain and strain rate, and these are related to the AF burden. Echocardiographic assessment of LA structural and functional remodeling is quick and feasible and may be helpful in predicting outcomes in AF. 18
Cystatin C and Contrast-Induced Acute Kidney Injury
Summary: Contrast-induced acute kidney injury represents a powerful predictor of unfavorable outcome. Serum creatinine (sCr) suffers from several limitations. Cystatin C (CyC) is more sensitive than sCr to rapidly detect acute changes in renal function. Preliminary data suggest that the increase of CyC achieves a maximum within 24 hours after contrast media exposure. We measured CyC together with sCr in 410 consecutive patients with chronic kidney disease undergoing contrast media exposure. Contrast-induced acute kidney injury (defined as sCr increase Ն0.3 mg/dL at 48 hours) occurred in 34 patients (8.2%). A CyC increase in concentration Ն10% at 24 hours after CM exposure was the best CyC cutoff for the early identification of patients developing contrast-induced acute kidney injury (negative predictive valueϭ100%; positive predictive valueϭ39.1%). Major adverse events (including death from any cause and dialysis) at 12 months occurred in 5.4% of patients with increase in CyC Ͻ10% and sCr Ͻ0.3 mg/dL (group 1), in 18.4% of patients with only a CyC increase Ն10% (group 2), and in 29% of patients with both CyC Ն10% and sCr Ն0.3 mg/dL (group 3). By logistic regression analysis, the independent predictors of major adverse events at 1 year were criteria of group 2 (odds ratioϭ2.52; 95% confidence interval, 1.17-5.41; Pϭ0.02), criteria of group 3 (odds ratioϭ4.45; 95% confidence interval, 1.72-11.54; Pϭ0.002), and baseline glomerular filtration rate (odds ratioϭ0.91; 95% confidence interval, 0.88 -0.95; PϽ0.001). In patients with chronic kidney disease, CyC seems to be a reliable marker for the early diagnosis and prognosis of contrast-induced acute kidney injury.
Conclusions:
In patients with chronic kidney disease, CyC seems to be a reliable marker for the early diagnosis and prognosis of contrast-induced acute kidney injury. 19 a worse outcome from revascularization compared with nondiabetics. Improvement in medical treatment strategies for these patients could have a large clinical impact. We have shown that DPP-4 inhibitors can produce an acute beneficial effect to protect against ischemic left ventricular dysfunction. Further studies are required to examine whether GLP-1 agents such as DPP-4 inhibitors or GLP-1 receptor agonists could have chronic beneficial effects on the heart for the diabetic with coronary disease. The potential cardiac use of GLP-1 may also be broader than the treatment of stable coronary artery disease. Its pharmacological properties as a cardioprotective agent are attractive. It is well tolerated with minimal side effects and there is very low risk of hypoglycemia which obviates the need for concomitant glucose infusion. Further work is needed to assess its potential benefits in other clinical settings such as in patients with heart failure or in acute coronary syndromes.
The augmentation of GLP-1 7-36 by inhibition of DPP-4 improves global and regional LV performance in response to stress and mitigates postischemic stunning in humans with coronary artery disease. 20
Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain: Comparison With Ejection Fraction and Wall Motion Scoring
Summary: Global left ventricular systolic function is an important determinant of mortality, and ejection fraction (EF) is the most widely applied parameter for its measurement. Unfortunately, EF has a number of important technical limitations, and, despite its use as an arbiter of therapy (eg, defibrillator implantation), it is often qualitatively assessed. There is a need for a simple and automated quantitative alternative to EF. Global longitudinal speckle strain (GLS) is such an automated technique for measurement of long-axis function, which has been shown to correlate with EF, and we sought in this study to identify whether it could be used for the prediction of mortality. In this study of 546 consecutive individuals undergoing echocardiography for assessment of resting left ventricular function, Simpson biplane EF was measured and GLS was calculated from 3 standard apical views using 2D speckle tracking. The incremental value of EF and GLS to significant clinical variables was assessed in nested Cox models. Although addition of EF (hazard ratio, 1.23; Pϭ0.03) added to the predictive power of clinical variables, the addition of GLS (hazard ratio, 1.45; PϽ0.001) caused the greatest increment in model power (x 2 ϭ34.9, PϽ0.001). A GLS Ն-12% was found to be equivalent to an EF Յ35% for the prediction of prognosis.
Conclusions: GLS is a superior predictor of outcome to either EF or wall motion score index and may become the optimal method for assessment of global left ventricular systolic function. 21
Frequency of Myocardial Bridges and Dynamic Compression of Epicardial Coronary Arteries: A Comparison Between Computed Tomography and Invasive Coronary Angiography
Summary: Myocardial bridging is clinically significant when associated with regional hemodynamic alterations, and studies have shown that such instances of myocardial bridging are linked to clinical complications that include ischemia, acute coronary syndrome, coronary spasm, arrhythmia, and sudden death, although in the vast majority of cases, myocardial bridging remains clinically silent. The wide discrepancy in the reported prevalence of myocardial bridging between autopsy findings and those of conventional angiography has been attributed to instances of myocardial bridging that do not cause dynamic compression. Recently, CT angiography has been suggested as a tool in the diagnosis of myocardial bridging, with an average depiction rate between that of autopsy and conventional angiography but with a wide variation among authors. In the present study, the frequency of myocardial bridging by CT angiog-raphy was 58%, and conventional angiography revealed dynamic compression in 13.3% of all cases. The correlation between CT and conventional angiography revealed that dynamic compression occurred almost exclusively (97.5%) in cases with full encasement of the left anterior descending coronary artery, regardless of the measurable presence of overlying muscle in CT. This finding is useful for more accurately detecting instances of myocardial bridging that are likely to produce dynamic compression. Entrapment within the interventricular gorge, a new hypothesis for the mechanism of dynamic compression, along with other factors suggested by earlier researchers, appears to play a pivotal role in producing dynamic compression, and this observation may pave the way for further research into myocardial bridging.
Conclusions: The frequency of myocardial bridging observed by CT angiography was 58%, and conventional, angiography revealed dynamic compression in 13.3% of total patients. Dynamic compression occurred almost, exclusively (97.5% of the time) in patients with full encasement of the left anterior descending coronary artery, regardless of the presence of overlying muscle. 22
Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Summary: Patients with transfusion-dependent anemias such as thalassemia major die primarily of heart failure caused by myocardial siderosis. Significant recent advances in the prevention of cardiac mortality include the robust identification of the level of iron loading in the heart with T2* cardiovascular magnetic resonance and improved treatments to remove cardiac iron quickly while reducing the toxicity of iron-mediated reactive oxygen species. However, the drive to treat myocardial siderosis aggressively has not been guided by an understanding of the clinical outcomes in relation to the severity of myocardial siderosis. In this multicenter prognostic study of thalassemia major patients, we show that the risk of progression to heart failure is present dominantly with myocardial T2* Ͻ10 ms and that the risk climbs steeply with further reductions in T2* (increasing myocardial siderosis). Likewise, there is increased likelihood of progression to both atrial and ventricular arrhythmias with increasing myocardial siderosis but with a higher T2* threshold, indicating that other factors such as increased atrial sensitivity to iron and chronic atrial stretch from raised cardiac output may be involved. These data form a new bedrock for risk assessment in clinical practice for the need to treat myocardial siderosis and in particular show that cardiac T2* is a significantly better predictor of cardiac events than the established measures of liver iron and serum ferritin. T2* cardiovascular magnetic resonance has significant potential to lead to the eradication of heart failure-related death in transfusion-dependent anemias when it is available and effective cardiac chelation can be instituted and maintained.
Conclusions: Cardiac T2* magnetic resonance identifies patients at high risk of heart failure and arrhythmia from myocardial siderosis in thalassemia major and is superior to serum ferritin and liver iron. Using cardiac T2* for the early identification and treatment of patients at risk is a logical means of reducing the high burden of cardiac mortality in myocardial siderosis. 23
Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study
Summary: Infective endocarditis is a disease characterized by high morbidity and mortality. In patients with left-sided infective endocarditis, the occurrence of acute brain embolization has significant implications for prognostication and clinical decision making. In this preliminary study, we found that systematic use of MRI of the brain detected the presence of subclinical brain embolization in a substantial proportion of patients in whom there was no clinical evidence of stroke. This finding was particularly prevalent among patients with Staphylococcus aureus as the causative organism. Patients with clinical stroke and those with subclinical brain embolization had similar baseline characteristics and survival, suggesting that clinical stroke and subclinical brain embolization may have similar clinical implications. However, patients with clinical or MRI evidence of brain embolization had significantly higher mortality at 3 months than those without such findings. No patient with acute brain embolization who underwent cardiac surgery suffered a postoperative neurological complication. If these findings are confirmed in larger studies, brain MRI may assume a wider role with respect to treatment decisions in patients with left-sided infective endocarditis.
Conclusions: MRI detected subclinical brain embolization in a substantial number of patients with left-sided infective endocarditis, suggesting that the incidence of acute brain embolization may be significantly higher than reports based on clinical and computed tomography findings have indicated. Brain MRI may play a role in the complex decision about surgical intervention in infective endocarditis. 24
Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study
Summary: Atherosclerotic plaque inflammation is thought to be central to plaque rupture and, by extension, clinical events such as acute coronary syndrome, stroke, and transient ischemic attack. By identifying such plaques before symptoms become apparent, preventive therapies such as statins might be initiated or intensified. Fluorodeoxyglucose positron-emission tomography/computed tomography is already established for cancer diagnosis, staging, and the prediction of tumor response to therapy. Our study applied this noninvasive imaging technology to atherosclerosis of the carotid, femoral, and iliac arteries and the aorta. We explored the links between plaque inflammation, arterial calcification, circulating biomarkers, and atherogenic risk factors. We found that there was strong symmetry in the distribution of arterial inflammation and that calcification was inversely linked with inflammation. We also confirmed previous work by demonstrating that arterial inflammation was greater in male patients and in those with a diagnosis of coronary artery disease. Clinical applications of this work may include the use of imaging for prediction of plaque rupture, insight into the pathobiology of atherosclerosis, and monitoring of antiatherosclerosis therapies. Underpinning these applications, studies are already underway that will link imaging findings with clinical events. In addition, fluorodeoxyglucose positronemission tomography/computed tomography atherosclerosis imaging is already being used as a surrogate marker of antiatherosclerotic drug efficacy by several pharmaceutical companies seeking to exploit its uniquely high sensitivity and reproducibility.
Conclusions: This study shows that fluorodeoxyglucose positronemission tomography can increase our knowledge of how atherosclerotic plaque inflammation relates to calcification, serum biomarkers, and vascular risk factors. Plaque inflammation and calcification rarely overlap, supporting the theory that calcification represents a late, burnt-out stage of atherosclerosis. Inflammation in one arterial territory is associated with inflammation elsewhere, and the degree of local arterial inflammation is reflected in the blood levels of several circulating biomarkers. We suggest that FDG PET imaging could be used as a surrogate marker of both atherosclerotic disease activity and drug effectiveness. Prospective, event-driven studies are now underway to determine the role of this technique in clinical risk prediction. 25
Cardiac Positron Emission Tomography/ Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease
Summary: Accurate noninvasive assessment of coronary artery disease is a challenging task. In a cohort of 107 patients at intermediate clinical risk, we measured the power of hybrid positron emission tomography and computed tomography coronary angiography against invasive coronary angiography with fractional flow reserve for the detection of obstructive coronary artery disease. Although both computed tomography angiography and positron emission tomography individually were able to rule out significant coronary artery disease (negative predictive value, 97%), both approaches showed only modest positive predictive value. Positron emission tomography perfusion imaging alone could not always separate microvascular dysfunction from epicardial stenoses, whereas computed tomography angiography was limited in defining the physiological significance of anatomic stenosis. Hybrid positron emission tomography/computed tomography significantly improved this accuracy to 98%. This was achieved with a rapid 30-minute imaging protocol with a reasonable radiation dose (Ͻ10 mSv) to the patient. These data suggest that hybrid positron emission tomography/computed tomography imaging of the heart is a feasible, accurate method to assess coronary artery disease noninvasively in a symptomatic, moderate-risk patient population.
Conclusion: Cardiac hybrid positron emission tomography/computed tomography imaging allows accurate noninvasive detection of coronary artery disease in a symptomatic population. The method is feasible and can be performed routinely with Ͻ10 mSv in most patients. 26 
Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Summary: We recently reported a high prevalence of intracardiac thrombi at autopsy in patients with cardiac amyloid. We also found that intracardiac thrombi resulted in embolism and significant mortality, which was often unappreciated clinically. Thus far, neither the prevalence nor the effect of anticoagulation on intracardiac thrombi has been evaluated antemortem. We therefore studied transesophageal echocardiograms of cardiac amyloid patients at the Mayo Clinic. The prevalence of intracardiac thrombosis, clinical and transthoracic/transesophageal echocardiographic risks for intracardiac thrombosis, and effect of anticoagulation were investigated in 156 patients with cardiac amyloidosis who underwent transesophageal echocardiograms. Primary amyloid (AL) was present in 80 patients, and other types of amyloid were present in 76 patients, including 56 with the wild transthyretin type, 17 with the mutant transthyretin type, and 3 with a secondary type. There was a high prevalence of intracardiac thrombi (42 of 156 patients, 27%). Patients with AL amyloid had thrombi more often than the other types (35% versus 18%; Pϭ0.02). Multivariate analysis showed that atrial fibrillation, poor left ventricular diastolic function, and lower left atrial appendage emptying velocity were independently associated with increased risk for intracardiac thrombosis; anticoagulation was associated with a significantly decreased risk. We suggest that clinicians consider evaluation of intracardiac thrombosis in patients with cardiac amyloid, especially in patients with high-risk features such as atrial fibrillation, left ventricular diastolic dysfunction, and atrial mechanical dysfunction. Timely screening may allow earlier detection. The risks and benefits of anticoagulation can then be carefully considered.
Conclusions: Intracardiac thrombosis occurs frequently in cardiac amyloid patients, especially in the AL type and in those with atrial fibrillation. Risk for thrombosis increased if left ventricular diastolic dysfunction and atrial mechanical dysfunction were present. Anticoagulation therapy appears protective. Timely screening in high-risk patients may allow early detection of intracardiac thrombus. Anticoagulation should be carefully considered. 27 
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans
Summary: Diffuse myocardial fibrosis is a final common end point in cardiovascular disease and is associated with symptoms, impaired ventricular function, and adverse prognosis. Even though it is thought to be a key "missing parameter" in clinical cardiology, and it is a target for many therapies (eg, angiotensin-converting enzyme inhibitors, aldosterone antagonists), it can only be quantified by histology on biopsy, with inherent risk and sampling error. As a result, it is not well understood in the clinical arena. Echocardiographic surrogates such as markers of diastolic dysfunction are unsatisfactory because they are influenced by multiple other factors. We developed and performed initial validation for a new technique, equilibrium contrast cardiovascular magnetic resonance (EQ-CMR), as a method to quantify diffuse myocardial fibrosis. We designed it to be easy to implement on any scanner. EQ-CMR involves standard MRI technology and contrast agent and can be integrated into a standard CMR protocol. We have shown that EQ-CMR correlates with histological fibrosis in 2 conditions, aortic stenosis and hypertrophic cardiomyopathy. This work is at an early stage, but it appears that, for the first time, it is possible to measure the diffuse myocardial fibrosis burden noninvasively. With further work, this technique could have widespread implications in disease characterization, monitoring, outcome prediction, and therapeutics.
Conclusions:
We have developed and validated a new technique, EQ-CMR, to measure diffuse myocardial fibrosis as an add-on to a standard CMR scan, which allows for the noninvasive quantification of the diffuse fibrosis burden in myocardial diseases. 28
Complementary Prognostic Values of Stress Myocardial Perfusion and Late Gadolinium Enhancement Imaging by Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease
Summary: Cardiac magnetic resonance (CMR) reversible myocardial perfusion defect (RevPD) has demonstrated not only high accuracy in detection of flow-limiting coronary stenosis but also strong prognostic value in risk stratifying patients presenting with suspected ischemia. With high tissue contrast and spatial resolution, CMR late gadolinium enhancement (LGE) imaging is the most sensitive current imaging technique for detecting small subendocardial infarction that elevates a patient's risk of cardiac events. In a clinical cohort of 254 patients referred for stress CMR imaging, we tested the hypothesis that RevPD and LGE imaging in a single CMR study can provide complementary prognostic values for major adverse events, including cardiac death or nonfatal myocardial infarction (MI). Although RevPD and LGE both demonstrated strong unadjusted association with death/MI (hazard ratio, 6.88 and 5.32, respectively; both PϽ0.0001), robust association with death/MI by RevPD and LGE was maintained when the effects of these variables were adjusted for each other and for patient age and gender. In patients without a history of MI who were found to have no RevPD, the presence of LGE portended a Ͼ11-fold hazards increase in death/MI. We found that patients with both RevPD and LGE absent had the most favorable annual negative event rate for death/MI at Ͼ98%. We therefore conclude that CMR stress myocardial perfusion and LGE imaging performed in a CMR study provide complementary prognostic implication for cardiac death or acute nonfatal MI.
Conclusions: CMR imaging provides robust risk stratification for patients who present with symptoms of ischemia. Characterization of RevPD and LGE by CMR provides strong and complementary prognostic implication for cardiac death or acute MI. 29
Applicability of Appropriateness Criteria for Stress Imaging: Similarities and Differences Between Stress Echocardiography and Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging Criteria
Summary: We applied stress echocardiography appropriateness criteria to patients undergoing stress echocardiography at an academic medical center. The results were compared with those obtained using the single-photon computed tomography myocardial perfusion imaging criteria in the same patients. With these criteria, patient indications can be classified as appropriate, uncertain, inappropriate, or not classifiable. Applying these criteria was feasible, with good interrater agreement. One in 5 patients was not classifiable, however, suggesting significant gaps in the stress echocardiography criteria. Of the patients, 19% were classified as inappropriate. The clinical situations that were most often inappropriate by these criteria, such as asymptomatic patients with low-risk Framingham scores, symptomatic patients with low pretest probability of coronary artery disease, an interpretable ECG, and the ability to exercise, and patients scheduled for low-risk surgery, are instances that do not warrant screening with stress echocardiography according to existing guidelines. Efforts aimed at minimizing the overuse of stress imaging could focus on these clinical situations. Fewer patients were classified as appropriate by the stress echocardiography criteria (54%) than by the single-photon computed tomography myocardial perfusion imaging criteria (64%), confirming that the stress echocardiography appropriateness criteria are stricter. Future refinements of the appropriateness criteria for stress imaging should address gaps in the criteria and disparities between the stress echocardiography and single-photon computed tomography myocardial perfusion imaging criteria.
Conclusions: Applying stress echocardiography appropriateness criteria to a patient population is feasible, although 1 in 5 of our patients was not classifiable. Overall, the stress echocardiography criteria classified patients differently compared with the SPECT MPI criteria. Future refinements of the appropriateness criteria for stress imaging should address gaps in the criteria and disparities between the stress echocardiography and SPECT MPI criteria. 30
Prevalence and Clinical Significance of Papillary Muscle Infarction Detected by Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With ST-Segment Elevation Myocardial Infarction
Summary: Although late gadolinium-enhanced MRI provides superb imaging of the heart with high tissue contrast and spatial resolution, little attention has been given to the detection of papillary muscle infarction (PapMI). In addition, the relationship between papillary muscle dysfunction and mitral regurgitation has been controversial in patients with ST-segment elevation myocardial infarction. In the present study, we assessed the incidence of PapMI without rupture and its effects on left ventricular morphology and mitral regurgitation using cardiac MRI in 118 patients with STsegment elevation myocardial infarction. PapMI was identified in up to 40% of patients, mainly in nonanterior myocardial infarction. The posterior papillary muscle was involved more frequently than the anterior papillary muscle (77% versus 26%; PϽ0.001). At the acute phase, mitral regurgitation was observed in 34 patients (28.8%). Coaptation height was the independent predictor of the presence of mitral regurgitation by multiple logistic regression analysis. At the 8-month follow-up, infarct size showed a positive correlation with left ventricular end-diastolic volume (rϭ0.41, PϽ0.001), and the presence of PapMI was not associated with left ventricular remodeling. Deterioration of mitral regurgitation did not occur in patients with PapMI. Larger-scale and longer-term follow-up studies are required to confirm the impact of PapMI on left ventricular remod-
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Conclusions: PapMI is more frequent than previously thought yet appears to have significant clinical latency. The size of the myocardial infarction, but not the presence of PapMI, seems to affect left ventricular remodeling, and PapMI is not obligatorily associated with MR. 31
Ventricular Geometry, Strain, and Rotational Mechanics in Pulmonary Hypertension
Summary: As a result of ventricular interdependence, analysis of concomitant intrinsic left ventricular (LV) diseases (ie, myocardial fibrosis) in patients with significant pulmonary hypertension (PH) is challenging. The farther a region is from the right ventricle (eg, the lateral wall), the less the impact will be that the PH has on LV strain. Furthermore, parameters based on circumferential fibers appear to propagate farther from the right ventricle than longitudinal parameters, likely reflecting continuity of the circumferential fibers from the septum to the lateral wall. Accordingly, a finding of abnormal LV lateral wall longitudinal strain in patients with PH might identify true LV dysfunction that is independent of PH. We further demonstrated that LV torsion correlated negatively with estimated pulmonary artery systolic pressure and with septal flattening. Abnormally reduced LV torsion in PH could represent an advanced stage of PH and geometric alteration. Interestingly, although torsion was reduced, untwisting velocity was similar regardless of pulmonary artery systolic pressure. This may reflect the known association of rapid untwisting with reduced LV end-systolic volume, a likely compensatory mechanism to maintain filling in the presence of reduced preload and/or exercise. Further study defining the relationship of LV torsion and untwisting with clinical outcomes and evaluating the effect of PH therapy on LV torsion is needed.
Conclusions: Chronic right ventricular (RV) pressure overload directly affects RV longitudinal systolic deformation. RV pressure overload further influences interventricular septal (IVS) and LV geometry, which impairs LV torsion and segmental LS and circumferential strain, more for the IVS than for the free wall of the LV. 32
Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation
Summary: Current American College of Cardiology/American Heart Association and European Society of Cardiology guidelines recommend mitral valve surgery for asymptomatic patients with severe degenerative mitral regurgitation and preserved left ventricular systolic function when atrial fibrillation or pulmonary hypertension (PHT) is present. The American College of Cardiology/American Heart Association guidelines state that mitral valve surgery is reasonable in such patients in the presence of exercise PHT (defined as a systolic pulmonary arterial pressure Ͼ60 mm Hg, Class IIa, Level of Evidence C). In this study, 78 consecutive asymptomatic patients with preserved left ventricular systolic function and moderate or severe mitral regurgitation were submitted to resting and exercise echocardiography. The results show that exercise PHT is frequent, is related to exercise mitral regurgitation severity, and is associated with 3.4-fold increase in the risk of development of symptoms. The best cutoff value of exercise systolic pulmonary arterial pressure was 56 mm Hg, which is close to the empirical threshold of 60 mm Hg used in the American College of Cardiology/ American Heart Association guidelines. We found that exercise PHT is more accurate than resting PHT for predicting symptoms. Hence, exercise echocardiography appears to be useful in patients with asymptomatic degenerative mitral regurgitation for revealing the increase in mitral regurgitation severity and the presence of PHT during exercise and thus identifying patients at risk of developing symptoms rapidly. Close follow-up (3-6 months) is advised in asymptomatic patients developing exercise PHT. Prompt surgery to prevent adverse left atrial remodeling, irreversible left ventricular damage, and morbid events could potentially be indicated in these patients. On the other hand, a strategy of watchful waiting seems to be more appropriate in patients without exercise PHT.
Conclusions: Exercise PHT is frequent in patients with asymptomatic degenerative mitral regurgitation. Exercise mitral regurgitation severity is a strong independent predictor of both exercise systolic pulmonary arterial pressure (SPAP) and exercise PHT. Exercise PHT is associated with markedly low 2-year symptom-free survival, emphasizing the use of exercise echocardiography. An exercise SPAP Ͼ56 mm Hg accurately predicts the occurrence of symptoms. 33
Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease
Summary: The diagnosis of myocardial ischemia with magnetic resonance myocardial perfusion imaging (MRMPI) has a number of potential advantages over other available noninvasive tests. The majority of previous studies have assessed the clinical utility of MRMPI by comparing it with quantitative coronary angiography, which at intermediate degrees of stenosis has been shown to be a poor indicator of the functional severity of coronary heart disease. The present study in 101 patients with suspected angina is the largest study to assess the accuracy of MRMPI compared with an invasive physiological measurement of the significance of coronary artery disease, namely fractional flow reserve. Fractional flow reserve values of Ͻ0.75 have been shown to indicate functionally significant coronary heart disease. Visual analysis of MRMPI scans was compared with fractional flow reserve and quantitative coronary angiography. We have shown that with fractional flow reserve as the gold standard, MRMPI can detect functionally significant coronary heart disease with a sensitivity and specificity of 91% and 94% and positive and negative predictive values of 91% and 94%, respectively. Comparing MRMPI with quantitative coronary angiography led to a reduction in specificity and positive predictive value. We have shown that MRMPI is an excellent test for the diagnosis of significant coronary heart disease compared with the invasive gold standard of fractional flow reserve. It is hoped that our study will promote the use of MRMPI as a radiation-free alternative test for the noninvasive detection of reversible myocardial ischemia.
Conclusion: MRMPI can detect functionally significant coronary heart disease with excellent sensitivity, specificity, and positive and negative predictive values compared with fractional flow reserve. 34
Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer

18
F-BMS-747158 to 02: Comparison to 13 
N-Ammonia and Validation With Microspheres in a Pig Model
Summary: Because of its unique ability to quantify regional myocardial perfusion in absolute terms, positron-emission tomography (PET) provides high sensitivity for detection of coronary artery disease and allows evaluation of early abnormalities in coronary vasoreactivity in patients at risk. However, the short half-life, on the order of minutes, of typical myocardial blood flow PET tracers limits its clinical use, unless an on-site cyclotron is available. 18 F-BMS-747158 to 02 is a novel 18 F-labeled PET perfusion tracer that targets the mitochondrial complex. Its longer half-life allows distribution from a central cyclotron facility. In the present study, we evaluated its imaging properties in a large animal model using a clinical PET scanner and validated its use for quantification of myocardial blood flow using kinetic modeling. 18 F-BMS-747158 to 02 PET provided excellent image quality that allowed accurate delineation of perfusion defects caused by transient constriction of a coronary artery.
Ratios of 18 F-BMS-747158 to 02 uptake between the heart and surrounding tissues, including liver, lung, and blood, were significantly higher than those of the current standard tracer, ammonia. Compared with the "gold standard," microspheres, 18 F-BMS-747158 to 02 PET proved to be highly accurate in measuring blood flow over a wide range of flow values under rest and pharmacological stress. Thus, 18 F-BMS-747158 to 02 is a very attractive new PET perfusion tracer that provides excellent image quality and quantitative measures of regional myocardial perfusion. These, combined with its long tracer half-life, indicate that this tracer has potential in the clinical workup of patients with suspected or proven coronary artery disease.
Conclusions: 18 F-BMS-747158 to 02 is a very attractive new PET perfusion tracer that allows quantitative assessment of regional myocardial perfusion over a wide flow range. The long half-life of 18 F renders this tracer useful for clinical PET/CT applications in the workup of patients with suspected or proven coronary artery disease. 35 
Integration of Infarct Size, Tissue Perfusion, and Metabolism by Hybrid Cardiac Positron Emission Tomography/Computed Tomography: Evaluation in a Porcine Model of Myocardial Infarction
Summary: Early after myocardial infarction, several pathophysiological mechanisms may be triggered that contribute to subsequent postinfarction remodeling and transition to heart failure. Early detection of such mechanisms by noninvasive imaging, along with a better understanding of their interrelations and implications, may improve individual postinfarction therapy. This study uses innovative hybrid positron emission tomography/computed tomography technology to identify postinfarction inflammation and microvascular obstruction early after acute myocardial infarction, which appear to be partially interrelated. The work done in an animal model may stimulate further clinical studies to investigate the clinical role of the imaging findings.
Conclusions: Perfusion/metabolism positron emission tomography and delayed enhancement coronary tomography (CT) can be combined within a single hybrid positron emission tomography/coronary tomography session. Increased regional [ 13 N]-ammonia/[ 18 F]deoxyglucose uptake in the acute infarct area is frequently observed. In contrast to the chronic infarct setting, this indicates tissue inflammation that is commonly associated with microvascular obstruction as identified by no reflow on CT. The consequences of these pathophysiological findings for subsequent ventricular remodeling should be explored in further studies. 36 
Comparison of Aortic Root Dimensions and Geometries Before and After Transcatheter Aortic Valve Implantation by 2-and 3-Dimensional Transesophageal Echocardiography and Multislice Computed Tomography
Summary: Current 2D echocardiographic techniques assume circular aortic root geometry when calculating cross-sectional areas. Previous studies have demonstrated that the aortic annulus and left ventricular outflow tract have an ellipsoid geometry but failed to quantify the extent of underestimation caused by this geometric assumption. This may have important clinical implications for selection of appropriate transcatheter aortic valve sizes, which is currently based on 2D echocardiographic measurements. Furthermore, changes in the aortic root dimensions and geometries after transcatheter aortic valve implantations are unknown. Using multislice computed tomography as the "clinical gold standard," the present study quantified the degree of aortic root cross-sectional area underestimation caused by the assumption of circular aortic annular and left ventricular outflow tract geometry. Furthermore, we demonstrated that 3D transesophageal echocardiography had the best agreement with multislice computed tomography. Finally, after transcatheter aortic valve implantations, the left ventricular outflow tract and aortic valve annulus became more circular-shaped. The use of 3D imaging may have implications in the calculation of aortic valve area by continuity equation and the selection of appropriate transcatheter aortic valve sizes.
Conclusions: Before transcatheter aortic valve implantations (TAVI), 2D and 3D transesophageal echocardiography (TEE) aortic annular/left ventricular outflow tract (LVOT) circular geometric assumption underestimated the respective multislice computed tomography (MSCT) planimetered areas. After TAVI, 3D TEE and multislice computed tomography (MSCT) planimetered annular areas decreased as it assumes the internal dimensions of the prosthetic valve. However, planimetered LVOT areas increased due to a more circular geometry. 37
A Study of Functional Anatomy of Aortic-Mitral Valve Coupling Using 3D Matrix Transesophageal Echocardiography
Summary: To date, several imaging modalities have been used to separately study the functional anatomy of the aortic and mitral valve. However the coupling between the aortic and mitral valves in 3D was studied only in animals using invasive markers. In humans, the newly developed transesophageal real-time 3D echocardiography is increasingly playing an important role in the assessment of functional anatomy of these valves. To our knowledge, this is the first study to develop and test a noninvasive technique for detailed characterization of aortic valve dynamics and quantitative evaluation of mitral and aortic valvular coupling throughout the cardiac cycle in a beating human heart using this new technology. Our results demonstrate the potential of this methodology to quantify parameters describing aortic and mitral valve functional anatomy in three dimensions and their coupling. Our findings underscore the need to consider the aortic and mitral valves jointly, rather than as separate entities, not only because they are linked anatomically, but also because the dynamic changes in their shape and position are reciprocally correlated. This technology will allow the assessment of the impact of a variety of mitral and aortic rings on the annular dynamics.
Conclusions: This is the first study to report quantitative 3D assessment of the mitral and aortic valve dynamics from matrix array transesophageal images and describe the mitral-aortic coupling in a beating human heart. This ability may have impact on patient evaluation for valvular surgical interventions and prosthesis design. 38
Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function: Noninvasive Assessment by Cardiac Magnetic Resonance and Echo
Summary: Myocardial fibrosis develops as a final common end point in response to a broad range of cardiac pathologies such as ischemia, inflammation, hypertension, and valvular heart disease. Clinically, these conditions may produce signs and symptoms related to increased myocardial stiffness that may result from replacement or reactive fibrosis. This study used late gadolinium enhancement cardiac magnetic resonance to noninvasively quantify myocardial fibrosis and Doppler echocardiography to detect and classify severity of left ventricular diastolic dysfunction. Regardless of etiology, the presence and severity of diastolic dysfunction increased with the greater extent of myocardial fibrosis. This work suggests that late gadolinium enhancement cardiac magnetic resonance may be useful to identify the myocardial substrate for impaired relaxation and provides a rationale for its use as an end point in developing novel therapeutics for diastolic dysfunction.
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Conclusions: Severity of myocardial fibrosis by late postgadolinium myocardial enhancement significantly correlates with the degree of diastolic dysfunction in a broad range of cardiac conditions. Noninvasive assessment of myocardial fibrosis may provide valuable insights into the pathophysiology of left ventricular diastolic function and therapeutic response. 39
Association Between Aneurysm Shoulder Stress and Abdominal Aortic Aneurysm Expansion: A Longitudinal Follow-Up Study
Summary: By convention, abdominal aortic aneurysm (AAA) diameter has been used as an indicator of the potential risk of rupture. Advances in biomechanics have enabled us to assess the inherent stresses within the aneurysm wall, which are thought to play a role in aneurysm expansion. From the structural view point, aneurysm expansion and rupture results from material fatigue and failure of the aneurysm wall. In this study we assessed the association of AAA wall stresses with their expansion rates and found that stresses at the shoulder of the rapidly expanding aneurysms had good correlation with the expansion rates compared with slowly expanding aneurysms. We also tested the relationship of maximum diameter of the aneurysm to its expansion rate, but although such a relationship is widely believed to exist, we found no such relationship. This highlights the fact that biomechanical stress analysis of AAAs may be useful for estimating their expansion rather than relying only on maximum AAA diameter for assessment of potential risk of rupture.
Conclusion: A higher shoulder stress was found to have an association with a rapidly expanding AAA. Therefore, it may be useful for estimating the expansion of AAAs and improve risk stratification of patients with AAAs. 40
Viability Assessment With Global Left Ventricular Longitudinal Strain Predicts Recovery of Left Ventricular Function After Acute Myocardial Infarction
Summary: The extent of viable myocardial tissue is recognized as a major determinant of recovery of left ventricular (LV) function after myocardial infarction. In the current study, the role of global LV strain (as a marker of viable myocardium) assessed with novel automated function imaging (AFI) to predict functional recovery after acute infarction was evaluated. Baseline AFI global LV strain was strongly related to viability assessed with single-photon emission computed tomography. Importantly, baseline AFI global LV strain (within 48 hours after infarction) was a predictor for change in LV ejection fraction at 1-year follow-up. A cutoff value for baseline AFI global LV strain of -13.7% yielded a sensitivity of 86% and a specificity of 74% to predict LV functional recovery at 1-year follow-up. An advantage of this novel echocardiographic technique is the fact that quantification of AFI global LV strain is performed at rest only. No additional acquisitions during exercise are needed. Furthermore, patients are not exposed to radiation. Therefore, assessment of AFI global LV strain using echocardiography may be used as an accessible imaging technique to determine viability and subsequent probability of recovery of LV function after acute myocardial infarction.
Conclusions: AFI global LV strain early after acute myocardial infarction reflects myocardial viability and predicts recovery of LV function at 1-year follow-up. 41
Molecular Imaging of Innate Immune Cell Function in Transplant Rejection
Summary: Since the advent of effective immunosuppressive regimens, cardiac transplantation has become a routine treatment of end-stage heart failure. Acute rejection episodes occur in most heart transplant recipients during the first year after surgery, and their severity and frequency seem to predict the long-term survival of the graft. Thus, rapid and precise detection of graft rejection is vital. Repetitive invasive endomyocardial biopsies remain the most commonly performed diagnostic test but are invasive, increase morbidity, and have a considerable sampling error. The development of a noninvasive yet quantitative diagnostic tool to identify graft rejection would significantly improve the care of heart transplant recipients.
Assessing macrophage-host responses by the use of recently developed molecular and cellular imaging techniques could provide a noninvasive alternative. As a result of the uncertainty about which macrophage functions provide the most useful markers for detecting parenchymal rejection, we compared 2 imaging probes reporting on key macrophage functions, protease activity and phagocytosis. In vivo imaging with both probes provided a functional 3-dimensional map of macrophage accumulation, with the signal intensity correlated to the severity of graft rejection. The imaging approaches described here could advance the investigation of novel therapeutic strategies and the longitudinal assessment of individualized immunosuppressive regimens, and their application may well facilitate the monitoring of transplant recipients.
Conclusions: Molecular imaging reporters of either phagocytosis or protease activity can detect cardiac allograft rejection noninvasively, promise to enhance the search for novel tolerance-inducing strategies, and have translational potential. 42
Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or Both
Summary: Mechanical dyssynchrony has been considered an independent predictor for adverse outcomes in patients with heart failure. However, its importance after myocardial infarction is not well understood. We assessed the influence of mechanical dyssynchrony on clinical outcomes in 381 patients with left ventricular dysfunction, heart failure, or both after acute myocardial infarction. Dyssynchrony severity at baseline was associated with older age; hypertension; history of myocardial infarction, heart failure, and longer QRS duration; less percutaneous coronary angioplasty; greater left ventricular and left atrial volumes, left ventricular mass index, infarct length, and mitral regurgitation; and lower left ventricular ejection fraction. Moreover, we observed the independent prognostic value of mechanical dyssynchrony in predicting death or heart failure in this population. These data suggest that the contractile pattern itself may play a role in prognosis after myocardial infarction independently of global and regional contractile function.
Conclusion: Left ventricular dyssynchrony is independently associated with increased risk of death or heart failure after myocardial infarction, suggesting that contractile pattern may play a role in post-myocardial infarction prognosis. 43
Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction
Summary: Delayed-enhancement MRI (DE-MRI) is increasingly being used for myocardial variability assessment because it is reproducible, has high spatial and contrast resolution, and can be performed without exposing patients to ionizing radiation. To date, there are only a few reports on the prognostic value of DE-MRI. In the present study, a total of 857 patients who underwent DE-MRI were followed up for a median of 4.4 years. The primary end point was composite all-cause mortality and cardiac transplantation. The degree of DE was assessed qualitatively and was expressed as the scar index. We found that the presence of DE predicted worse transplant-free survival. Scar index was a significant independent predictor of death/cardiac transplantation even after adjustment for traditional prognosticators. In patients with preserved systolic func- 
High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis
Summary: Accumulation of macrophages influences clinical outcomes of various inflammatory diseases, including atherosclerosis. Particularly, these proinflammatory phagocytes promote not only development of atherosclerosis but also its acute thrombotic complications. Development of novel circulating or imaging biomarkers targeting macrophages should thus help to identify patients with subclinical inflamed lesions and to provide new and important insights into preventive cardiovascular medicine. Molecular or functional imaging, a rapidly emerging technology, visualizes biological or pathological processes in specific organs or disease contexts, in addition to providing anatomic information. The present study represents modern molecular imaging that can assess vascular inflammation. We demonstrate that high-resolution 3-T MRI enhanced with superparamagnetic iron nanoparticles can measure inflammatory burden in atherosclerosis of hypercholesterolemic rabbits. Macrophages internalize such iron particles, most likely via phagocytosis, thus changing the magnetic field in inflamed tissues. The present study demonstrates that the magnitude of T2-weighted signal intensity loss, reflecting phagocytic activity of macrophages, is associated positively with the extent of accumulation of these immune cells in atherosclerotic plaques. Such a noninvasive imaging approach might also offer a powerful tool to monitor the effects of anti-inflammatory therapies in clinical practice or during clinical trials for new drugs. Our study indeed reports that the magnitude of T2-weighted signal intensity loss significantly decreased after statin treatment and correlated well with the reduction of lesional macrophage accumulation. Furthermore, such macrophage-targeted molecular imaging should provide novel insight into the mechanisms of atherosclerosis and its acute complications.
Conclusion:
The magnitude of T2 signal intensity reduction in highresolution MRI after administration of superparamagnetic phagocytosable nanoparticles can assess macrophage burden in atheromata, providing a clinically translatable tool to identify inflamed plaques and to monitor therapy-mediated changes in plaque inflammation. 45
Relationship of Echocardiographic Dyssynchrony to Long-Term Survival After Cardiac Resynchronization Therapy
Summary: This study demonstrated the association of echocardiographic dyssynchrony with long-term survival after cardiac resynchronization therapy (CRT). We studied 229 consecutive patients with routine CRT indications (symptomatic heart failure, reduced ejection fraction, and widened QRS Ն120 milliseconds), of whom 210 (89%) had baseline echocardiographic dyssynchrony data available. Dyssynchrony was prespecified as tissue Doppler longitudinal velocity opposing-wall delay Ն65 milliseconds, 12-site SD (Yu Index) Ն32 milliseconds, speckle tracking radial strain anteroseptalto-posterior wall delay Ն130 milliseconds, or pulsed Doppler inter-ventricular mechanical delay Ն40 milliseconds. Of 210 patients, there were 62 unfavorable events over 4 years after CRT: 47 deaths, 9 transplantations, and 6 left ventricular assist device implantations. All echocardiographic dyssynchrony indexes were significantly associated with a more favorable long-term prognosis than for patients without dyssynchrony, except tissue Doppler velocity opposing-wall delay became significant at Ն80 milliseconds. When adjusted for covariates of ischemic pathogenesis and QRS width, the Yu Index and speckle tracking radial strain remained independently predictive of outcome. Subgroup analysis demonstrated that patients with narrower QRS width of 120 to 150 milliseconds who lacked radial dyssynchrony had a particularly poor survival. Although this study has identified the absence of echocardiographic dyssynchrony as a marker for a less favorable prognosis in patients who undergo CRT for routine indications, the potential influence of CRT on outcome in patients without dyssynchrony remains unknown. These observations strongly support the association of echocardiographic dyssynchrony with long-term patient outcome after CRT.
Conclusions:
The absence of echocardiographic dyssynchrony was associated with significantly less favorable event-free survival after CRT. Patients with narrower QRS duration who lacked dyssynchrony had the least favorable long-term outcome. These observations support the relationship of dyssynchrony and CRT response. 46
"Vascular Age" Is Advanced in Children With Atherosclerosis-Promoting Risk Factors
Summary: Childhood obesity is a public health problem in the United States. Obese children may have multiple risk factors such as dyslipidemia, insulin resistance, and hypertension, which promote premature atherosclerosis and heart disease. Because clinical cardiovascular end points are not manifest in children, assessment of the vasculature noninvasively by performing carotid artery ultrasound and measuring carotid artery intima-media thickness to quantify the impact of these coexisting risk factors on the vasculature can be a useful tool in clinical practice. In this report, we analyzed the carotid artery intima-media thickness (a measure of subclinical atherosclerosis) in 70 children ages 6 to 19 years who were referred to the Preventive Cardiology Clinic of a Children's Hospital for evaluation of familial dyslipidemia or obesity with dyslipidemia and other atherosclerosis-promoting risk factors. Forty of the 70 children were obese and 75% of obese children had multiple coexisting atherosclerosis-promoting risk factors. Children were assigned as having an advanced "vascular age" if their carotid artery intima media thickness was comparable to that seen in sex-and race-matched 45-yearold adults. Per this definition, advanced "vascular age" was seen in 75% of all children and was noted as often in obese children compared with children with familial dyslipidemia. Carotid artery ultrasound can be performed in an outpatient clinic setting and may add incremental information to that of risk factor measurements alone. Children with risk factors and an advanced "vascular age" may need more intensive nonpharmacological and pharmacological therapies for risk factor modification.
Conclusions: Vascular age (VA) is advanced and comparable in obese children with atherosclerosis-promoting risk factors and in children with familial dyslipidemia. Advanced VA is prevalent in obese children with high fasting triglyceride levels. 47
Impact of Mild Hypertension on Left Atrial Size and Function
Summary: Several reports have demonstrated that left atrial size can be used as a marker for the severity of diastolic dysfunction and as a prognostic marker of future cardiovascular events. In addition, an enlarged left atrium predisposes to the development of atrial fibrillation with its associated morbidity and mortality. This prospective study demonstrates that the diastolic dysfunction consequent to mild hypertension (blood pressure Ͻ160/100 mm Hg) is associated with preserved atrial passive emptying and conduit volumes, with an
The Editors Most Read in Imaging e877 increase in active atrial emptying volume. These data suggest that the increased "left ventricular stiffness" consequent to mild hypertension may play a role in the recruitment of starling forces and thus may be the mechanism responsible for left atrial dilatation. Our data additionally indicate that echocardiographically determined left atrial size may be a useful method to monitor the efficacy of antihypertensive therapy and the adequacy of blood pressure control.
Conclusion: Even mild hypertension seems to be associated with a reduction in early diastolic filling. This results in augmented late left ventricular diastolic filling due to active atrial contraction and may be the mechanism for the increase in left atrial size. 48
Vascular Inflammation in Patients With Impaired Glucose Tolerance and Type 2 Diabetes: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
Summary: Inflammatory atherosclerotic plaque has been established as a main contributing factor responsible for cardiovascular disease. Type 2 diabetes mellitus is not only an independent risk factor for atherosclerotic cardiovascular disease but is also associated with increased levels of inflammatory markers. There is growing, consistent evidence that quantitative positron emission tomography with 18 F-deoxyglucose can provide a noninvasive measure of vascular inflammation. In this study, we found increased 18 F-deoxyglucose uptake in patients with impaired glucose tolerance and type 2 diabetes mellitus compared with the healthy subjects, even though there were no significant differences in the carotid intima-media thickness across the groups. This result suggests that vascular inflammation detected by positron emission tomography with 18 F-deoxyglucose may reflect an earlier stage in atherogenesis that is manifested before anatomic changes can be detected by ultrasonography.
Conclusions:
The results of the present study suggest that impaired glucose tolerance and type 2 diabetes mellitus are associated with vascular inflammation in carotid atherosclerosis detected by 18F-Fluorodeoxyglucose Positron Emission Tomography. 49
Molecular Magnetic Resonance Imaging of Myocardial Angiogenesis After Acute Myocardial Infarction
Summary: Angiogenesis is a natural relief mechanism to restore perfusion to ischemic myocardium after acute myocardial infarction. Therapeutic angiogenesis is being explored as a novel treatment option for myocardial infarction patients; however, sensitive, noninvasive in vivo measures of therapeutic efficacy are lacking and need to be developed. Here, a molecular MRI method is presented to noninvasively image angiogenic activity in vivo in a murine model of myocardial infarction with a targeted, bimodal (ie, paramagnetic and fluorescent) contrast agent. Intravenous injection of the contrast agent resulted in a strong increase in image contrast in the infarcted myocardium. Significantly less change in image contrast was found in myocardial infarction mice injected with a control contrast agent or in sham-operated mice injected with the targeted agent. The MRI results were confirmed by ex vivo fluorescence microscopy, which also demonstrated significant microvascular remodeling in the infarction and border zones of the heart in response to myocardial infarction. Future clinical applications of the presented molecular MRI method include early noninvasive evaluation of proangiogenic therapy, prediction of improvements in myocardial perfusion and function based on the early angiogenic response, risk stratification, development of individualized therapy, and monitoring of drug delivery.
Conclusions: Cyclic Asn-Gly-Arg (cNGR)-labeled paramagnetic quantum dots (pQDs) allow selective, noninvasive detection of angiogenic activity in the infarcted heart with the use of in vivo molecular MRI and ex vivo 2-photon laser scanning microscopy. 50
Unreliable Assessment of Necrotic Core by Virtual Histology Intravascular Ultrasound in Porcine Coronary Artery Disease
Summary: Intravascular ultrasound-derived virtual histology (VH IVUS) is currently used extensively in clinical research, and necrotic core area assessed with VH IVUS is used as a primary end point in clinical trials. VH IVUS has also been proposed as a potential vulnerable plaque detector, based on its capability to assess the area of the necrotic core of thin-cap fibroatheromas. However, VH IVUS has never been validated for assessment of necrotic core area. In this animal study, we found that VH IVUS did not reliably assess necrotic core area in porcine coronary artery disease. This finding raises concern about using necrotic core area, as assessed by VH IVUS, as an end point in clinical trials. It should also alert clinicians using VH IVUS in the catheterization laboratory about the potential pitfalls of using this to identify vulnerable plaque until more fully validated.
Conclusions:
We found no correlation between necrotic core size determined by VH IVUS and real histology, questioning the ability of VH IVUS to detect rupture-prone plaques, so-called thin-cap fibroatheromas. 51
Diagnostic Accuracy and Impact of Computed Tomographic Coronary Angiography on Utilization of Invasive Coronary Angiography
Summary: Currently, invasive coronary angiography (ICA) is the gold standard for the diagnosis of obstructive coronary artery disease (CAD). However, ICA is best reserved for patients who benefit most from coronary revascularization. Identifying a noninvasive modality that can accurately diagnose obstructive CAD is desirable. Computed tomographic coronary angiography (CTA) is an emerging modality that has a high negative predictive value and, given its ability to rule out CAD, may have a role as a gatekeeper for ICA. To better understand the impact of cardiac CT on clinical practice, a study was undertaken to determine the diagnostic accuracy and clinical impact of CT coronary angiography on the utilization of ICA. CTA had excellent per-patient sensitivity (99%), positive predictive value (92%), and negative predictive value (95%) for obstructive CAD. As expected (due to referral and verification bias), the specificity (64%) was lower than that of previously published studies; however, the normalcy rate of CTA was 94%. After adjusting for referral bias, the adjusted sensitivity was 90%, and the adjusted specificity was 95%. With the implementation of a cardiac CT program, the frequency of normal ICA decreased significantly from 31.5% to 26.8% which was significantly different from centers without dedicated cardiac CT (30.0% to 31.0%) during the same time periods. The results of this study confirm the potential utility of CTA for the diagnosis of obstructive CAD and its potential for improving utilization of ICA by reducing the frequency of patients with nonobstructive CAD requiring ICA.
Conclusion:
The clinical implementation of CTA appears to positively impact ICA by reducing the frequency of normal ICA. The operating characteristics of CTA support its potential role as a tool useful in ruling out obstructive coronary artery disease. 52 potentially hazardous wall parameters clearly correlated with markers for individual bifurcation geometry. The diameter ratio of the internal and common carotid artery, the bifurcation angle, and tortuosity may provide early predictors for regions prone to atherosclerosis. Changes in the topology of atherogenic wall parameters indicated that stenosis in the carotid bifurcation can result in the relocation of critical wall parameters to segments distal to the atherosclerotic lesion and that therapeutic intervention can result in similar wall parameter distribution as observed in healthy volunteers. Flow-sensitive 4D MRI may become a valuable technique to assess the individual risk of flow-mediated atherosclerosis and carotid plaque progression.
Conclusions: Flow-sensitive 4D MRI identified alterations in the segmental in vivo wall shear stress distribution associated with atherosclerotic disease, surgical therapy, and individual bifurcation geometry and could be a valuable technique to assess the individual risk of flow-mediated atherosclerosis and carotid plaque progression. 53
Validation of 3-Dimensional Speckle Tracking Imaging to Quantify Regional Myocardial Deformation
Summary: Left ventricular regional wall motion analysis based on measurement of myocardial deformation is one focus of cardiac ultrasound imaging technology. Two-dimensional speckle tracking imaging has been introduced to assess left ventricular myocardial strain. However, 3D wall motion such as cardiac translation and rotation affect the accuracy of stain measurements by 2D speckle tracking imaging. Therefore, 3D speckle tracking imaging may be a more reliable method of assessing regional left ventricular strain.
Recently, a robust 3D speckle tracking imaging system was developed and introduced on a commercially available ultrasound system. Because the accuracy of regional strain assessment has not been validated, we performed an experimental study to validate the accuracy of 3D speckle tracking imaging. We measured radial, circumferential, and longitudinal strain components and compared these data with strain data from sonomicrometry taken at baseline, during pharmacological stress tests, and during acute myocardial ischemia. Significant correlations were observed between strain measurements by 3D speckle tracking imaging and those by sonomicrometry. This experimental study, the first to validate the accuracy of 3D speckle tracking imaging in the assessment of left ventricular regional strain, suggests that 3D speckle tracking imaging is a reliable technique for assessing left ventricular regional strain and is a powerful tool to assess left ventricular function in detail in the clinical setting.
Conclusions:
The newly developed 3D speckle tracking imaging (3D-STI) technique can estimate LV regional circumferential, longitudinal, and radial strain components with reasonable correlation to sonomicrometry data. This methodology could be applied clinically to assess alteration of myocardial function by accurately measuring strain in basal, mid, and apical LV segments, even during pharmacological and ischemic interventions. Therefore, 3D-STI appears to be a reliable tool to assess LV regional wall function. 54
Diffusion Spectrum MRI Tractography Reveals the Presence of a Complex Network of Residual Myofibers in Infarcted Myocardium
Summary: Muscle fibers in the myocardium spiral around the left ventricle with a helix angle that is determined by their transmural location. This myofiber architecture influences both the mechanical and electric properties of the left ventricle and is perturbed in injured myocardium. The impact of altered myofiber architecture, however, remains poorly understood in large part because of the difficulty in assessing this in vivo. In the current article, we describe a technique known as diffusion spectrum MRI tractography (DSI tractography) to image 3D myofiber architecture in vivo. The technique is based on the preferential diffusion of water along myofibers, which creates a detectable change in the MR signal when an appropriate magnetic gradient is applied. DSI tractography represents a significant advance over previously developed techniques in that multiple fiber populations can be resolved in a single voxel, supporting the construction of robust myofiber tractograms. DSI tractography was used to image normal and infarcted rat myocardium in this study. We show that a complex network of residual myofibers persists within portions of the infarcted myocardium, linking the infarct zone to the border zone. We show, moreover, that these residual myofibers can form abnormal connections with each other. The use of DSI tractography could thus provide valuable insights into both electric and mechanical events in infarcted myocardium. The translation of the technique to humans will require some modifications but is feasible. DSI tractography thus has the potential to become a highly valuable tool in the cardiovascular imaging armamentarium.
Conclusions: DSI tractography resolves 3D myofiber architecture and reveals a complex network of orthogonal myofibers within infarcted myocardium. Meshlike networks of orthogonal myofibers in infarcted myocardium may resist mechanical remodeling but also probably increase the risk for lethal reentrant arrhythmias. DSI tractography thus provides a new and important readout of tissue injury after myocardial infarction. 55
Strain Echocardiography and Wall Motion Score Index Predicts Final Infarct Size in Patients With Non-ST-Segment-Elevation Myocardial Infarction
Summary: Infarct size is a strong prognostic indicator after myocardial infarction. In patients with ST-segment elevation myocardial infarction, reperfusion therapy is effective in reducing infarct size and has improved survival. However, a proportion of non-STsegment-elevation myocardial infarction patients also experience substantial myocardial infarction, but these patients are rarely eligible for acute reperfusion therapy. Severe myocardial ischemia and necrosis is not always reflected in ST segment elevation, and these patients often do not reveal clinical signs of instability. Hence, there is a need for other modalities to identify these patients. Abundant evidence has demonstrated that myocardial ischemia causes rapid deterioration of myocardial systolic function. Echocardiography is a fast and available tool for estimation of myocardial systolic function. Left ventricular ejection fraction and wall motion score index are conventional parameters used to estimate left ventricular systolic function. Recently, strain measurement by speckle tracking has emerged as a new modality. The present study demonstrates that non-ST-segment-elevation myocardial infarction patients with substantial myocardial infarction can be identified by echocardiographic parameters of left ventricular systolic function. Global longitudinal strain and wall motion score index both demonstrate excellent discriminating power. Echocardiography and particularly strain echocardiography may facilitate the evaluation of interventions that impact outcomes in patients with non-ST-segment-elevation myocardial infarction.
Conclusions: Echocardiographic parameters of LV systolic function correlate to infarct size in patients with non-ST-segment-elevation myocardial infarction. Global longitudinal strain and wall motion score index are both excellent parameters to identify patients with substantial myocardial infarction, who may benefit from urgent reperfusion therapy. 56
Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques
Summary: Inflammatory cells, particularly macrophages, are believed to undermine the stability of atherosclerotic plaques, promoting plaque
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rupture and subsequent life-threatening thrombosis. The present study represents a novel approach in imaging inflammation in atherosclerosis by imaging macrophage function and the activity of a key effector enzyme, myeloperoxidase, which is known to trigger oxidative reactions. Unlike measurement of the presence of phagocytes, measurement of myeloperoxidase activity in plaques is likely to have greater specificity to identify vulnerable plaques. This molecular imaging technology can potentially localize plaques with active inflammation before devastating thromboembolic events occur.
Conclusions:
The present study represents a unique approach in the detection of inflammation in atherosclerotic plaques by examining macrophage function and the activity of an effector enzyme to noninvasively provide both anatomic and functional information in vivo. 57
Myocardial Perfusion Scans: Projected Population Cancer Risks From Current Levels of Use in the United States
Summary: This article provides population-based estimates of lifetime cancer risk from nuclear myocardial perfusion scans and other cardiac imaging tests for comparison. Positron emission tomography and dual-isotope scans have the lowest and highest radiation exposures, respectively. Cancer risks are low, ranging from 2 cancers per 10 000 scans (95% uncertainty interval, 1-5) for ammonia-13 cardiac positron emission tomography to 25 cancers per 10 000 scans (95% uncertainty interval, 9 -58) for dual-isotope studies. However, because of widespread use of nuclear myocardial perfusion studies (9.1 million scans per year in the United States), it is possible that 7400 additional future cancers could be related to these scans. These risk estimates depend on several assumptions, including the assumption that the cancer risk and radiation dose have a linear no-threshold relationship even at low doses and that the life expectancy for individuals undergoing the scans is similar to that of the general population. The clinician should be familiar with the indications for nuclear myocardial perfusion studies and order scans in accordance with the American Heart Association/American College of Cardiology appropriateness criteria guidelines. In the future, newer technologies with lower radiation exposure and adequate sensitivity and specificity for disease detection may be preferred.
Conclusions:
The lifetime cancer risk from a single myocardial perfusion scan is small and should be balanced against likely benefit and appropriateness of the test. The estimates depend on a number of assumptions, including life expectancy. They apply directly to asymptomatic individuals with life expectancies similar to those of the general population. For individuals with a symptomatic clinical profile, on whom such scans are typically performed, the risks will be lower because of shorter life expectancy. 58
Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization Therapy: Optimization of the Force-Balance Relationship
Summary: Cardiac resynchronization therapy (CRT) is associated with a reduction in functional mitral regurgitation (MR). However, the precise mechanism of MR reduction is incompletely defined. Normal mitral valve (MV) function results from a balance of both tethering and left ventricular (LV) closing forces on the MV. Tethering forces, transmitted via the chordae, keep the valve from prolapsing, whereas closing forces depend on the pressure generated by the ventricle to close the mitral valve. Functional MR results from a derangement in this force-balance relationship of tethering and closing forces. There are 2 potential mechanisms by which CRT may reduce MR. One mechanism relates to reverse remodeling effects of CRT on the LV and MV geometry, resulting in improved spatial relationships of the MV to the ventricle and reduction in leaflet tethering. A second mechanism relates to improved LV contraction with an increase in LV pressure generation after CRT and increased closing forces on the MV with improved leaflet coaptation. To better understand the mechanism of MR reduction after CRT, we examined LV and MV geometry using 3D echocardiography and the transmitral closing pressure pattern using Doppler echocardiography, at baseline and 6 months post-CRT. The latter is an integrated measure of LV force generation and reflects the coordinated impact of closing forces on the MV throughout systole. Our results show that MR reduction post-CRT is associated with both reduced tethering of the mitral valve through beneficial affects on LV remodeling and increased LV contraction forces on the mitral valve. It has been proposed that the mechanism of MR reduction relates to geometric change or, alternatively, changes in LV contractile function. Normal MV function relies on a balance between tethering and closing forces on the MV leaflets. Functional MR results from a derangement of this force-balance relationship, and CRT may be an important modulator of MV function by its ability to enhance the forcebalance relationship on the MV. We hypothesized that CRT improves the comprehensive force balance acting on the valve, including favorable changes in both geometry and LV contractile function.
Conclusions: Reduction in MR after CRT is associated with favorable changes in MV geometry and closing forces on the MV. It does so by favorably affecting the force balance acting on the MV in 2 ways: reducing tethering through reversal of LV remodeling and increasing the systolic duration of peak transmitral closing pressures. 59
Determinants of Left Ventricular Early-Diastolic Lengthening Velocity: Independent Contributions From Left Ventricular Relaxation, Restoring Forces, and Lengthening Load
Summary: Measurement of left ventricular early-diastolic lengthening velocity (e') by tissue Doppler echocardiography is used clinically to evaluate diastolic function, and the ratio between peak transmitral early-diastolic velocity and e' has been introduced as a noninvasive estimate of left ventricular diastolic pressure. A number of studies indicate that e' is closely related to the rate of left ventricular relaxation. The present experimental study indicates that left ventricular transmural pressure at the onset of diastolic filling, which represents a lengthening load (early-diastolic load), is another important independent determinant of e'. Clinically, lengthening load would approximate left ventricular end-diastolic pressure. The present study also indicates that restoring forces, analogous to the elastic recoil after release of a compressed spring, is another important independent determinant of e'. Experimentally, restoring forces were quantified as the magnitude of contraction below myocardial resting length. Clinically, this is reflected in end-systolic length and magnitude of contraction. The present study confirmed that rate of relaxation is an independent determinant of e'. In the normal heart, with rapid relaxation, lengthening load and restoring forces are probably the main determinants of early-diastolic lengthening velocity. The relative contribution of the different determinants may depend on the functional state of the ventricle, with a more important contribution from rate of relaxation during heart failure.
Conclusions:
The present study indicates that in the nonfailing ventricle, in addition to LV relaxation, restoring forces and lengthening load are important determinants of early-diastolic lengthening velocity. 60 determinant of postoperative prognosis. However, the best predictor for postoperative left ventricular systolic dysfunction in patients with chronic aortic regurgitation is still a matter of debate. The aim of this study was to assess the clinical significance of preoperative systolic radial strain rate (Ssr) derived from tissue Doppler echocardiography as a predictor of postoperative left ventricular systolic dysfunction in patients with chronic aortic regurgitation. In 52 patients with chronic aortic regurgitation, operation caused significant decreases in left ventricular dimensions and volumes and significant increase in Ssr and left ventricular ejection fraction. Multiple regression analysis demonstrated that averaged Ssr was the only independent predictor of postoperative left ventricular systolic dysfunction. Using receiveroperating characteristic curve analysis, averaged Ssr yielded the greatest area under the curve among preoperative parameters (0.80) and was identified as being a good predictor of postoperative left ventricular dysfunction, with 90.9% sensitivity and 73.2% specificity (cutoff value, 1.82 per second). The results of this study suggest that the measurement of Ssr may be a useful tool not only for estimation of subclinical myocardial dysfunction, but also for optimizing surgical timing, especially in patients for whom there is debate about the need for and timing of surgery.
Conclusions: Measurement of preoperative averaged Ssr is useful in predicting postoperative LV systolic dysfunction and optimizing surgical timing in patients with isolated chronic aortic regurgitation. 61
Apical Rotation Assessed by Speckle-Tracking Echocardiography as an Index of Global Left Ventricular Contractility
Summary: Left ventricular (LV) twist motion, induced by apical counterclockwise and basal clockwise rotation, leads to LV wringing or torsional deformation during systole, and this action is believed to generate the required pumping power. Noninvasive measurement of LV twist or rotation by speckle-tracking echocardiography or MRI shows great promise for new quantification of LV contractility or systolic function. In this animal study, simultaneous data acquisition of maximal positive dP/dt, a gold standard of LV contractility and LV rotation, by speckle-tracking echocardiography was performed during pharmacological modulation of LV inotropy before and after coronary ligation to validate whether LV rotation is an accurate index of LV global contractility. We have confirmed that apical rotation, not basal rotation, is sensitive to the changes of inotropic status and is more closely related to maximal positive dP/dt than LV ejection fraction, especially after development of regional wall motion abnormalities. Apical rotation alone showed comparable accuracy to LV twist. These observations could support easier clinical application of apical rotation measurement to assess LV contractility, as we do not have to try to obtain basal rotation, which is tricky and causes many technical problems. Clinical advantages of apical rotation over conventional LV ejection fraction in routine daily practice need to be investigated.
Conclusions: Apical rotation assessed by speckle-tracking echocardiography is an effective noninvasive index of global LV contractility and is more closely related to dP/dtmax than LV EF. 62
Right Ventricular Ischemic Injury in Patients With Acute ST-Segment Elevation Myocardial Infarction: Characterization With Cardiovascular Magnetic Resonance
Summary: Cardiovascular magnetic resonance (CMR) is being used increasingly in myocardial infarction imaging in both acute and chronic settings. Although most studies, thus far, have focused on the left ventricle (LV), CMR has been shown to be useful in evaluating ischemic right ventricular (RV) myocardial injury as well. In the present study, a total of 242 patients with reperfused acute STsegment myocardial infarction from 3 tertiary hospitals underwent CMR early and at 4 months after infarction. CMR included assess-ment of myocardial edema with the use of T2-weighted imaging, myocardial enhancement with the use of late gadolinium enhancement CMR, and biventricular function with the use of cine imaging. Ischemic RV injury was commonly present early after infarction, characterized by myocardial edema (51% of patients), late gadolinium enhancement (31% of patients) of RV free wall adjacent to jeopardized LV myocardium, and functional abnormalities. Remarkably, this pattern of RV injury was not limited to inferior LV infarcts but occurred in anterior infarcts as well. Follow-up CMR showed reversibility of acute RV dysfunction with limited permanent myocardial damage on late gadolinium enhancement imaging (10% of patients). These findings support previous clinical and animal studies showing that the RV is more resistant to ischemia than the LV and that acute postinfarction RV dysfunction is likely an expression of viable rather than irreversibly damaged myocardium. Moreover, it is important to realize that in patients with anterior LV infarction, ischemia may extend toward the adjacent RV free wall and lead to transient RV dysfunction.
Conclusions: Early postinfarction RV ischemic injury is common and is characterized by the presence of myocardial edema, late gadolinium enhancement, and functional abnormalities. RV injury is not limited to inferior infarcts but is commonly found in anterior infarcts as well. Cardiovascular magnetic resonance findings suggest reversibility of acute RV dysfunction with limited permanent myocardial damage at 4-month follow-up. 63
Evaluation of ␣ v ␤ 3 Integrin-Targeted Positron Emission Tomography Tracer 18 F-Galacto-RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice
Summary: The ␣ v ␤ 3 integrin is a cell-surface receptor that mediates cell-to-cell and cell-to-extracellular matrix connections. It can be highly expressed by macrophages and endothelial cells in atherosclerotic lesions. Therefore, it could serve as a biomarker of inflammation and neovascularization in atherosclerotic lesions that have been implicated as risk factors for acute plaque rupture. 18 F-galacto-RGD is a positron emission tomography tracer for imaging the level of ␣ v ␤ 3 integrin expression. We demonstrate that 18 F-galacto-RGD shows ␣ v ␤ 3 integrin-dependent uptake in atherosclerotic plaques in the aorta of hypercholesterolemic mice. Autoradiography of aortic tissue sections revealed higher 18 F-galacto-RGD accumulation in the atherosclerotic plaques than normal vessel wall. Plaque-to-normal vessel wall ratios were comparable to those of deoxyglucose. Although angiogenesis was not detected, 18 F-galacto-RGD uptake was associated with macrophage density in the plaques. In vivo imaging visualized 18 F-galacto-RGD uptake colocalizing with calcified lesions of the aortic arch, as seen on computed tomography angiography. The results indicate that 18 Fgalacto-RGD is a potential tracer for noninvasive imaging of inflammation in atherosclerotic lesions.
Conclusions: 18 F-Galacto-RGD demonstrates specific uptake in atherosclerotic lesions of mouse aorta. In this model, its uptake was associated with macrophage density. 18 F-Galacto-RGD is a potential tracer for noninvasive imaging of inflammation in atherosclerotic lesions. 64
Cardiac Mechanics in Mild Hypertensive Heart Disease: A Speckle-Strain Imaging Study
Summary: Clinical identification of high-risk hypertensive patients is desirable for preventive strategies. We hypothesized that abnormalities in regional systolic strain () may help identify such high-risk patients even when the ejection fraction is normal. Accordingly, the aim of the current study was to use echocardiographic speckle tracking imaging, a technique that is independent of ultrasound angle of interrogation, to identify subclinical global and regional systolic function abnormalities in hypertensive subjects with normal ejection fraction. Accordingly, 2D speckle strain imag-
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ing was performed in 104 subjects (52 hypertensive subjects, 53Ϯ12 years of age, and 52 control subjects, 49Ϯ13 years of age; Pϭ0.82), all of whom had normal ejection fraction. We measured systolic velocities as well as systolic strains. Our principal findings were that when compared with control subjects, hypertensive subjects had lower myocardial systolic velocities but similar values for in all 3 planes: longitudinal, radial, and circumferential. Among hypertensive subjects, significant inverse associations were found between left ventricular mass and global longitudinal (rϭ-0.51) and circumferential (rϭ-0.21; both PϽ0.05). To summarize, mild hypertensive heart disease with normal ejection fraction was associated with reduced myocardial velocities but normal global . We interpret these data as showing that velocity abnormalities occur early in hypertension, are related to ventricular geometry, and thus may be an appropriate target for preventive strategies because they occur before detectable abnormalities in global strain.
Conclusions: Hypertensive heart disease with normal ejection fraction is associated with reduced myocardial velocities and reduced regional function but normal global . Our data suggest that velocity abnormalities occur early in hypertension and may be an appropriate target for preventive strategies because they occur before abnormalities in global strain. 65
Prognostic Implications of Left Ventricular Filling Pressure With Exercise
Summary: Evidence of raised left ventricular filling pressure (based on the ratio of transmitral and annular velocities, E/e' ratio) during resting echocardiography holds important prognostic value. However, many patients with normal resting left ventricular filling pressure complain of exertional symptoms, and some of these demonstrate an increment of E/e' ratio with stress. The prognostic implications of this response, especially in relation to other prognostic markers such as ischemia, are undefined. This may be particularly important because many studies have failed to account for the influence of ischemia on diastolic function. This study demonstrates the adverse outcome associated with raised E/e' during exercise echocardiography. Importantly, more than half of the patients with raised E/e' with exercise had normal filling pressure at rest indicating the incremental information provided by exercise. This study shows that the prognostic value of exercise E/e' is independent of ischemia. Despite the similar outcomes associated with raised exercise E/e' and ischemia, treatment options for raised filling pressure are not known, and objective identification of those at risk may assist in the investigation of appropriate therapies.
Conclusions: Exercise E/e' is associated with cardiovascular hospitalization, independent of and incremental to inducible ischemia. 66
Evaluation of a Novel 18 F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats
Summary: Measurement of myocardial infarct size is an important clinical goal after an acute myocardial infarction for prognostic assessment as well as evaluation of therapeutic interventions. Positron-emission tomography (PET) is an accurate tool for the assessment of coronary artery disease and myocardial viability. However, the short half-life of the PET flow tracers currently used limits its clinical use because of the need for nearby cyclotron or generator. A novel 18 F-labeled radiotracer for the evaluation of myocardial perfusion and the assessment of myocardial infarct size with PET ( 18 F BMS747158-02) has been developed. The results of this experimental study showed that 18 F BMS747158-02 PET provides excellent image quality that allowed accurate measurement of infarct size after either permanent or transient coronary occlusion. Compared with the ex vivo 2 to 3-5-triphenyl tetrazolium chloride staining, there was a close correlation between the quantitative PET defect size and the true infarct size. Furthermore, analysis of left ventricular volumes and systolic function was feasible in the gated images. Myocardial 18 F BMS747158-02 PET imaging is a promising technique for evaluation of infarct size.
Conclusions: Myocardial 18 F BMS747158-02 PET imaging provides excellent image quality and uptake properties, enabling accurate evaluation of MI size and left ventricular function in rats. It is a promising technique for evaluation of MI size in clinical trials. 67
Multislice Computed Tomography in the Exclusion of Coronary Artery Disease in Patients With Presurgical Valve Disease
Summary: Current guidelines for the management of valvular heart disease recommend preoperative coronary angiography for the detection of concomitant coronary artery disease (CAD) in all male patients age 35 or older, all postmenopausal women, and in premenopausal women with any risk factors for CAD. These patients are usually submitted to coronary angiography by means of cardiac catheterization. This study sought to evaluate the potential role for multislice computed tomography (MSCT) to replace cardiac catheterization as first-line examination in this clinical context. The main finding of this investigation is that MSCT coronary angiography (CTA) can effectively rule out significant CAD in the vast majority of patients with valve disease, including those with atrial fibrillation. Furthermore, assessment of pretest probability and quantification of coronary artery calcification (CAC) before CTA can effectively allow further discrimination. Based on the study findings, the authors propose a protocol in which patients scheduled for elective valve surgery with low to intermediate probability of CAD would undergo CAC assessment before CTA. Patients with a calcium score Ͻ400 would then be submitted to CTA, whereas patients with a high probability of CAD and patients with a CAC Ͼ400 would be referred directly for invasive coronary angiography. With this approach, cardiac catheterization could be avoided in approximately 70% of the patients, without a significant number of patients undergoing both examinations (sparing unnecessary exposure to radiation).
Conclusions:
In the preoperative assessment of patients with predominant valvular heart disease, the diagnostic accuracy of 64-slice CTA for ruling out the presence of significant coronary artery disease is very good even when including patients with irregular heart rhythm. Using this approach, CAC quantification before CTA can be successfully used to identify patients who should be referred directly to invasive angiography, sparing unnecessary exposure to radiation. 68
Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome
Summary: Acute coronary syndromes are caused by rupture of an atherosclerotic plaque in a coronary artery, and inflammation is thought to play a major role in plaque instability. Leukotrienes are a class of proinflammatory signaling molecules involved in arterial wall inflammation, and 5-lipoxygenase is a key regulatory enzyme in the biosynthesis of leukotrienes. This double-blinded, randomized study examined the safety and efficacy of the 5-lipoxygenase inhibitor VIA-2291 in 191 patients treated for 12 weeks after an acute coronary syndrome. The primary study end point, whole blood stimulated leukotriene LTB4 at trough drug level, was reduced at all 3 VIA-2291 dose levels, with approximately 80% inhibition in Ͼ90% of patients in the highest dose group (100 mg daily). No serious adverse events were considered related to study drug. A subset of patients underwent a 64-slice coronary CT scan at baseline and after 24 weeks of treatment. New coronary plaques were observed in 5 of 18 (27.8%) placebo patients and 2 of 42 (4.8%) VIA-2291-treated patients (Pϭ0.01). A reduction in noncalcified plaque volume at 24 weeks was observed in VIA-2291-treated groups in the 34 of these 60 patients in whom this end point was analyzable (PϽ0.01). We conclude that VIA-2291 reduces leukotriene production at 12 weeks after an acute coronary syndrome. Preliminary data from the CT substudy suggest that such a reduction in leukotriene production may have a favorable effect on atherosclerosis at 24 weeks; however, this requires confirmation in a larger study.
Conclusions: VIA-2291 reduces leukotriene production at 12 weeks after an acute coronary syndrome. Preliminary data from the CT substudy suggest that such a reduction in leukotriene production may influence atherosclerosis; however, this requires confirmation in a larger study. 69
Sex-Specific Pediatric Percentiles for Ventricular Size and Mass as Reference Values for Cardiac MRI: Assessment by Steady-State Free-Precession and Phase-Contrast MRI Flow
Summary: The present study examined a healthy pediatric group large enough to serve as a reference for volumetric cardiac MRI. Age-and sex-specific percentiles for right and left ventricular volumes and mass of healthy children and adolescents from 8 to 20 years of age were established to serve as reference values in the evaluation of acquired and congenital heart disease. Significant sex differences were noted when indexing volumes to body surface area or height. In contrast, indexing ventricular volumes (but not mass) to body weight largely eliminated the sex differences and may therefore be attractive for daily use in pediatric cardiology. An individual patient's progression of ventricular size in relation to these percentile curves may inform the timing of or the response to medical or surgical treatment. This potentially will facilitate a more accurate diagnosis of ventricular dilation and ventricular hypertrophy by cardiac MRI in this age group, with potential impact on management decisions.
Conclusions: Percentiles for ventricular volumes and mass in healthy children have been established to serve as reference values in pediatric heart disease. Significant sex differences were noted when indexing volumes to body surface area or height. Unisex centiles related to weight may be considered for chamber volumes albeit not for mass. 70
Rapid 3D Phenotyping of Cardiovascular Development in Mouse Embryos by Micro-CT With Iodine Staining
Summary: Congenital heart disease is the most common serious birth defect in humans. Great strides have been made in our understanding of the molecular origins of cardiac defects through the use of the mouse as a model system. This is primarily because of our ability to create targeted mutations in mice. Microcomputed tomography, when used in conjunction with the staining methods described in the present study, offers a means to better analyze mutant mice to detect subtle cardiovascular abnormalities. This imaging methodology represents a powerful tool for better understanding the implications of genetic lesions that result in heart defects.
Conclusions: Micro-CT of iodine-stained tissue is a valuable technique for the characterization of cardiovascular development and defects in mouse models of congenital heart disease. 71
Safety of Contrast Agent Use During Stress Echocardiography in Patients With Elevated Right Ventricular Systolic Pressure: A Cohort Study
Summary: This study addressed the safety of ultrasound contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure as determined by resting tricuspid regurgitation peak velocity. During short-term and long-term follow up, our data showed no difference in rates for death or myocardial infarction compared with those who had not received contrast agent, despite a higher incidence of clinical comorbidities in the contrast cohort.
Conclusion: Right ventricular systolic pressure had no impact on predisposition to adverse outcomes in patients undergoing contrast stress echocardiography in the population studied. 72
In Vivo Detection of Vulnerable Atherosclerotic Plaque by MRI in a Rabbit Model
Summary: Rupture or erosion of vulnerable atherosclerotic plaque is responsible for a substantial number of deaths and disabilities worldwide. Thus, in situ detection of plaques at high risk of disruption and thrombosis may improve risk prediction and treatment of individuals with atherosclerotic disease. The present study describes the use of MRI to identify characteristics of vulnerable plaques in a rabbit model of controlled plaque disruption. Our findings are promising because they are noninvasive, do not entail the use of ionizing radiation or nephrotoxic contrast agents, and can be performed with clinical MRI scanners. Furthermore, the development and testing of drugs to stabilize vulnerable plaques is a major challenge. Because atherosclerosis progression in humans is slow and large patient numbers are required for pharmacological studies, the rabbit model could be used to test the efficacy of therapeutic strategies on plaque morphology. If future investigations find that arterial remodeling and gadolinium uptake have prognostic and clinical value in identifying vulnerable plaques, then the findings of this study can be expanded to monitor the effectiveness of interventions in humans.
Conclusions:
We demonstrate that in vivo MRI at 3.0 T detects features of vulnerable plaques in an animal model of controlled atherothrombosis. These findings suggest that MRI may be used as a noninvasive modality for localization of plaques that are prone to disruption. 73
Assessment of Radiation Dose in Patients Undergoing Coronary Computed Tomographic Angiography With 256-Slice Scanning
Summary: The dramatic advances in computed tomography (CT) technology over the past decade have facilitated the rapid evolution of coronary CT angiography (CCTA) and have enhanced its diagnostic value in the noninvasive assessment of coronary artery disease. However, concomitant with the rapidly advancing knowledge pertaining to CCTA and the booming availability of the technique have been the ever-increasing concerns for the patient doses and cancer risks associated with CCTA. Unfortunately, incomplete and contradicting data, attributed partly to the unceasing technology changes, have served to heighten confusion. This study provides estimates of organ doses (based on a novel methodology using patient-specific phantoms) and projected life attributable risks of radiogenic cancer (based on the BEIR-VII approach) in a clinical patient population undergoing CCTA with a 256-slice system. The cancer life attributable risks from CCTA exposure were found to depend significantly on body habits and to decrease steeply with age at exposure, whereas lung cancer constitutes the most probable detriment for both genders. The recent introduction of wide-detector CT systems in clinical practice has facilitated the routine use of prospectively ECG-gated CCTA. With this technique, the life attributable risks of cancer incidence associated with CCTA exposure were estimated to be as low as 1 in 4000 women and 1 in 13,500 men. These estimated life attributable risks of malignancy may inconsequentially increase lifetime intrinsic cancer risks and compare favorably with hypothetical cancer risks resulting from exposures from alternative imaging tests or screening procedures estimated for the identical patient cohort. Regardless, however, of the scant associated life attributable risks, CCTA exposure should be always carefully considered and clinically justified.
Conclusions:
The mean projected life attributable risks of radiationinduced cancer in a typical clinical patient cohort undergoing standard prospectively ECG-gated CCTA with a 256-slice scanner were found to inconsequentially increase the natural cancer incidence rates. 74
Quantitative Assessment of Mitral Regurgitation: Comparison Between Three-Dimensional Transesophageal Echocardiography and Magnetic Resonance Imaging
Summary: Quantification of the severity of mitral valve regurgitation by measuring regurgitant volume (Rvol) and effective regurgitant orifice area (EROA) is recommended in current clinical practice. The accuracy of 2-dimensional (2D) echocardiographic methods to quantify these 2 parameters is significantly lower than 3-dimensional (3D) echocardiography or MRI. Eccentric regurgitant jets or ellipsoid regurgitant orifices are important determinants of the accuracy of 2D imaging techniques. The advent of a 3D fully sampled matrix array transesophageal echocardiography (TEE) probe allows realtime acquisition of 3D images and direct visualization and measurement of highly asymmetrical EROA. The present study compared the accuracy of 2D TEE and 3D TEE for quantification of the severity of mitral regurgitation using MRI as method of reference. Compared with 3D TEE, 2D TEE underestimated the EROA by a mean of 0.13 cm 2 . In addition, 2D TEE underestimated the Rvol by 21.6% when compared with 3D TEE and by 21.3% when compared with MRI. In contrast, 3D TEE underestimated the Rvol by only 1.2% when compared with MRI. Finally, one third of the patients in grade 1 and Ն50% of the patients in grade 2 and 3, as assessed with 2D TEE, would have been upgraded to a more severe grade, based on the 3D TEE and MRI measurements. Faced with the prognostic implications of mitral valve regurgitation, implementation of 3D TEE in the routine clinical practice may provide more accurate quantification of the severity of the regurgitant lesion and improve the clinical decision-making of these patients.
Conclusions: Quantification of mitral EROA and Rvol with 3D TEE is feasible and accurate as compared with MRI and results in less underestimation of the Rvol as compared with 2D TEE. 75
Magnetic Resonance Imaging of Carotid Atherosclerotic Plaque in Clinically Suspected Acute Transient Ischemic Attack and Acute Ischemic Stroke
Summary: Ischemic stroke is a major source of morbidity and mortality in aging populations. The majority of ischemic stroke and precursor events of transient ischemic attack are cryptogenic, and therefore the medical management options for patients who have suffered transient ischemic attack/ischemic stroke are severely limited. Even after a full acute stroke/transient ischemic attack medical workup, clinicians are often left with no treatable source for the event and are therefore limited to risk factor modification and optimization of medical treatments for diabetes mellitus, hypertension, and hyperlipidemia in patients who are at high risk for subsequent events. Atherosclerosis at the carotid bifurcation is likely the major source for transient ischemic attack/ischemic stroke. The methods to detect critical atherosclerotic disease have essentially been limited to the identification of severely stenotic lesions via lumenography for the last 50 years. Stenotic lesions are uncommon, and a large number of critical lesions are likely being missed because of limitations of atherosclerosis lesion detection and characterization. Through noninvasive MRI of the vessel wall, both stenotic and nonstenotic American Heart Association type VI atherosclerotic plaque demonstrating intramural hemorrhage, cap rupture, and/or thrombosis in situ can be identified. These type VI lesions are the likely source for cerebral thromboembolism as supported by the leading scientific models of thromboembolic stroke. If critical lesions can be identified, there is an opportunity for medical, surgical, or endovascular treatments of the patients who would benefit most. Furthermore, there would be an opportunity to monitor response to treatment. The potential clinical impact of MRI of vulnerable carotid bifurcation atherosclerosis is great.
Conclusions:
In situ type VI carotid bifurcation region plaque identified by MRI is associated with ipsilateral acute Transient Ischemic Attack and Acute Ischemic Stroke as an independent identifier of events, thereby supporting the dominant disease pathophysiology. 76
Prevalence of Coronary Artery Disease Assessed by Multislice Computed Tomography Coronary Angiography in Patients With Paroxysmal or Persistent Atrial Fibrillation
Summary: Coronary artery disease (CAD) is considered to be highly prevalent among patients with atrial fibrillation (AF) and may be one of its underlying causes. Furthermore, it has been suggested that AF may be the sole manifestation of CAD. However, most data supporting this association have been derived from studies using the presence of ECG abnormalities or a history of ischemic heart disease to define CAD rather than direct visualization of atherosclerosis. In this study, multislice computed tomography coronary angiography showed a higher prevalence of atherosclerosis and obstructive CAD in patients with AF, as compared with patients without AF, further supporting the hypothesis that AF could be a marker of advanced coronary atherosclerosis. It should be stressed, however, that multislice computed tomography coronary angiography does not provide information about the hemodynamic consequences of the observed coronary lesions (ie, ischemia or not). In patients with obstructive CAD on multislice computed tomography, functional testing remains needed to determine the presence of ischemia and to guide further therapeutic decisions.
Conclusion:
A higher prevalence of obstructive CAD was observed among patients with AF, confirming the hypothesis that AF could be a marker of advanced coronary atherosclerosis. 77
Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model
Summary: Cardiac magnetic resonance (MR) perfusion imaging during the first pass after intravenous administration of extracellular contrast agents is hampered by the spatial and temporal resolution achievable and by the artifacts seen in ultrafast MR imaging. Furthermore, time-consuming quantitative data analysis is often needed. The use of molecular MR imaging with a target-specific contrast agent with perfusion-dependent binding to myocardium may enable prolonged visualization of perfusion defects and thus may help to overcome limitations of currently used first-pass extracellular MR imaging. EP-3600 is a new gadolinium-containing small-peptide molecular contrast agent that binds reversibly to myocardial collagen. EP-3600 was investigated for myocardial perfusion imaging in a large-animal (swine) model of nonocclusive coronary stenosis. Molecular MR imaging was performed on a clinically used 1.5-T whole-body scanner with a sequence that can be used in humans during daily routine. It could be shown that remote myocardium demonstrates a significant signal increase over the entire examination time (60 minutes), whereas the perfusion defect was visible as a hypointense area for at least 20 minutes after intravenous contrast administration. Thus, EP-3600 enables prolonged, high-contrast, high-spatial-resolution visualization of myocardial perfusion de-fects in a human-size animal model and may lead to a paradigm shift in clinical cardiac perfusion MR imaging. This new approach could also enable the use of exercise stress outside the MR room instead of currently used drug-induced hyperemia inside the MR gantry.
Conclusion: EP-3600 is a new molecular MR imaging contrast agent that binds to the myocardium and enables prolonged, high-contrast, high-spatial-resolution visualization of myocardial perfusion defects. 78
Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty: Impact on Left Ventricular Function Assessed by Comprehensive Echocardiography and Gated Single-Photon Emission CT
Summary: Survivors of myocardial infarction with compromised left ventricular (LV) function are prone to experience adverse events, such as ventricular arrhythmia, heart failure, and death. A major target for primary coronary revascularization in patients with STsegment elevation myocardial infarction is to diminish postmyocardial infarction LV dysfunction. Previously, we have found adjunctive treatment by remote ischemic conditioning (ie, the application of intermittent peripheral limb ischemia during transport of patients to invasive treatment) to increase myocardial salvage. In the present study, we evaluated whether remote ischemic conditioning mediated a clinically relevant improvement of LV function using 2 independent methods: echocardiography and myocardial perfusion imaging.
In the total cohort, there was no significant effect, but in patients at a high risk of developing a large infarction (ie, patients with large myocardial area at risk and those with left anterior descending occlusion), remote conditioning improved LV ejection fraction and remodeling. Before wide clinical implementation of this low-cost and simple cardioprotective modality, trials confirming our findings as well as data on hard clinical outcomes are needed.
Conclusions: Although no significant overall effect was observed, remote ischemic conditioning seemed to result in modest improvement in LV function in high-risk patients prone to develop large myocardial infarcts. These results need to be confirmed in larger trials. 79
Prognostic Implications of Myocardial Perfusion Single-Photon Emission Computed Tomography in the Elderly
Summary: We assessed the clinical value of stress myocardial perfusion scintigraphy (MPS) in 5200 elderly patients (Ն75 years of age) followed up for 2.8Ϯ1.7 years (362 cardiac deaths, 7.0%, 2.6%/yr) and in a subset of 684 patients with extended follow-up (6.2Ϯ2.9 years; 320 all-cause deaths). The unadjusted cardiac death rate was 1.3%/yr after normal MPS but was Ͻ1% in patients with normal rest ECG, exercise stress, or age of 75 to 84 years and was 2.3% to 3.7% in patients Ն85 years of age or undergoing pharmacological stress. Importantly, compared with age-matched US population CD rates (75-84 years of age, 1.5%; Ն85 years of age, 4.8%), normal MPS cardiac death rates were approximately onethird lower than the baseline risk of US individuals (PϽ0.05 for both). Survival modeling of cardiac death revealed that MPS data yielded incremental value over pre-MPS data. The addition of gated MPS in a subset of 2472 patients showed that perfusion and ejection fraction data added incrementally to each other and enhanced risk stratification. Modeling of all-cause death in 684 patients with extended follow-up revealed that after risk adjustment, an interaction between early treatment and ischemia was present so that increasing ischemia was associated with increasing survival with early revascularization, whereas in the setting of little or no ischemia, medical therapy had improved outcomes. In an elderly population, stress MPS stratifies cardiac death risk in elderly patients and may identify optimal post-MPS therapy. Postnormal MPS cardiac death rates are low in all subsets in relative terms compared with the age-matched US population.
Conclusions: Stress MPS effectively stratifies CD risk in elderly patients and may identify optimal post-MPS therapy. CD rates after normal MPS are low in all subsets in relative terms compared with the age-matched US population. 80
Real-Time 3-Dimensional Echocardiography Provides New Insight Into Mechanisms of Tricuspid Valve Regurgitation in Patients With Hypoplastic Left Heart Syndrome
Summary: Significant tricuspid valve regurgitation is a major risk factor in hypoplastic left heart syndrome. Thus far, our understanding of the mechanisms responsible for tricuspid valve regurgitation is limited. In addition, surgical treatment of tricuspid regurgitation tends to be nonspecific, usually involving bicuspidization of the valve. Real-time 3-dimensional echocardiography may provide insight into the mechanisms of tricuspid valve regurgitation. This technique permits an evaluation of the spatial relationships between the tricuspid annulus, leaflets, and their supporting apparatus. Realtime 3-dimensional color Doppler also permits accurate evaluation of the severity of regurgitation. This cross-sectional study addressed the mechanisms of tricuspid valve regurgitation in a group of 35 patients with hypoplastic left heart syndrome, all of whom were at various stages after first-stage palliation. All had no more than mild regurgitation at the time of initial presentation. Real-time 3-dimensional echocardiography was used to extract spatial coordinates of the tricuspid annulus, leaflets, and supporting papillary muscles. Three-dimensional color Doppler was used to determine the severity of regurgitation. Analysis of the data revealed that moderate tricuspid regurgitation was associated with tethering and prolapse of the leaflets. Those with tethering had lateral displacement of the anterior papillary muscle and a more planar tricuspid annulus. On the other hand, prolapse was associated with a smaller septal leaflet area, older age, and annular dilatation. This study allows an improved understanding of the mechanisms of tricuspid valve regurgitation in hypoplastic left heart syndrome, with the potential to assist surgeons in targeting specific mechanisms.
Conclusion:
In hypoplastic left heart syndrome, moderate tricuspid regurgitation may be associated with increasing age, geometric changes of the annulus, leaflet prolapse, lateral papillary muscle displacement, and subsequent leaflet tethering, as well as a smaller septal leaflet. 81
Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes Mellitus
Summary: The underlying origin of diabetic heart disease is likely to be multifactorial, ranging from altered myocardial metabolism to endothelial dysfunction, microvascular disease, autonomic neuropathy, and altered myocardial structure with fibrosis. Increasing evidence is emerging on the role of lipotoxic myocardial injury from lipid oversupply. Using MRI and proton magnetic resonance spectroscopy, the present study evaluated the association between myocardial triglyceride accumulation and altered biventricular myocardial function by 2-dimensional speckle tracking echocardiography in type 2 diabetic patients. Diabetic patients with high myocardial triglyceride content had significantly more impaired biventricular myocardial functions despite normal volumes and ejection fraction. On multivariate analyses, myocardial triglyceride content was an independent determinant of biventricular myocardial functions. Future studies assessing the effectiveness of antisteatotic therapy in type 2 diabetic patients may include quantifications of myocardial triglyceride content by spectroscopy and assessments of myocardial functions by strain/strain rate imaging on 2-dimensional speckle tracking echocardiography.
Conclusions: High myocardial triglyceride content is associated with more pronounced impairment of LV and RV functions in men with uncomplicated type 2 diabetes mellitus. 82
Reduced Systolic Torsion in Chronic "Pure" Mitral Regurgitation
Summary: Uncorrected chronic ischemic mitral regurgitation (CIMR) is associated with decreased left ventricular (LV) torsion and may contribute to a vicious cycle wherein "MR begets MR." It has not been definitively established, however, whether the reduced LV torsion in CIMR is a direct result of the infarct, the MR, or a combination of the two. Currently, the most common technique to restore valve competence in patients with CIMR is the placement of an undersized annuloplasty ring. There exists, however, an ongoing debate about whether or not mitral valve annuloplasty at the time of coronary artery bypass grafting (CABG) improves outcomes over and above CABG alone. Hypothetically, if the reduction in LV torsion can be attributed to MR alone, then mitral valve repair concomitant with CABG may be important for minimizing the deterioration in LV torsion. Chronic "pure" MR was created in 13 sheep by surgically punching a 3.5-to 4.8-mm hole (HOLE) in the mitral valve posterior leaflet. Nine control (CNTL) sheep were operated on concurrently. At 1 (WK-01) and 12 weeks (WK-12) postoperatively, the 4D motion of implanted radiopaque markers was used to calculate global LV torsion. Global LV systolic torsion decreased in HOLE from WK-01 to WK-12 (4.1Ϯ2.8°versus 1.7Ϯ1.7°, PϽ0.01) but did not change in CNTL (5.5Ϯ1.8°versus 4.2Ϯ2.7°, PϭNS). These data suggest that in patients with CIMR the MR itself may promote deterioration of LV torsion. MV repair in patients with CIMR concomitant with CABG may therefore help to slow down, stop, or even restore physiological LV torsion.
Conclusions: Twelve weeks of chronic "pure" MR resulting in mild global LV remodeling is associated with significantly increased LV mass index and reduced global LV systolic torsion, but no other significant changes in hemodynamics. MR alone is a major component of torsional deterioration in "pure" MR and may be an important factor in chronic ischemic mitral regurgitation. 83
Aortopulmonary Collaterals After Bidirectional Cavopulmonary Connection or Fontan Completion: Quantification With MRI
Summary: Aortopulmonary collaterals (APCs) are frequent in patients with a so-called single ventricle physiology. On the basis of previous reports that linked the presence of APCs to a higher incidence of complications after the Fontan completion, foremost prolonged pleural effusions, most institutions coil-occlude large APC. Recently, however, this practice has been challenged by studies that did not confirm a deleterious effect of these channels. The contradicting nature of these reports may be related to the difficulty in assessing the magnitude of blood flow through collaterals angiographically. We are showing that APC flow volumes can be measured accurately and noninvasively in the majority of patients before and after Fontan completion. An increasing number of institutions are obtaining an MRI in their patients before proceeding to the Fontan completion. Artifacts from metallic implants which prevented APC flow measurement in 5 of our patients, will become less important and less frequent as MRI compatible devices are introduced. Phase contrast MRI can quantify the degree of left-toright shunting through APCs. From this pilot study, it is still unclear whether a large APC flow volume is associated with a worse clinical outcome. Even now, however, awareness of the hemodynamics, including the ratio of pulmonary to systemic blood flow and collateral blood flow, will help the clinician in obtaining a complete picture of the patient's status. Confirmation about a large left-to-right shunt can potentially guide therapy in a patient with single ventricle physiology and heart failure. Therefore, we believe that APC flow assessment should be performed in every patient with a bidirectional cavopulmonary connections or Fontan circulation who undergoes an MRI.
Conclusions: APC blood flow can be noninvasively measured in bidirectional cavopulmonary connections and Fontan patients, using MRI in the majority of patients and results in a significant left-toright shunt. 84
Ionizing Radiation Exposure to Patients Admitted With Acute Myocardial Infarction in the United States
Summary: Over the last decade, there has been a significant growth in the use of imaging studies involving ionizing radiation. Most authorities recommend a conservative strategy when considering tests involving ionizing radiation, in keeping with the "ALARA" (as low as reasonably achievable) principle while still being able to answer the clinical question. In this large retrospective study of 64 000 acute myocardial infarction episodes, we found that during a median 4-day acute myocardial infarction hospitalization, patients were exposed to a median radiation dose of 15 mSv, a dose that is 5 times the annual background level and a third of the annual limit for radiation workers. Thus far, the emphasis has focused on the radiation exposure for individual diagnostic tests and their associated doses in isolation. We believe a more important and actionable consideration may be the total cumulative radiation exposure that a patient receives during an episode of care for a given diagnosis. Rather than merely tracking total cumulative radiation exposure longitudinally, this new paradigm lends itself to an improved understanding of the specific predictors of radiation exposure by addressing radiation exposure per episodes of care. In so doing, we hope that ordering healthcare providers might also be encouraged to carefully consider the appropriateness of tests involving radiation and become even more mindful of their potential risks.
Conclusions: Acute myocardial infarction inpatients are exposed to an approximate median radiation dose of 15 mSv. This exposure is a result of multiple cardiovascular and noncardiovascular procedures. Efforts should be made to understand the risks and benefits of radiation exposure per episode of care for acute myocardial infarction. 85
Relationship Between Regional Myocardial Oxygenation and Perfusion in Patients With Coronary Artery Disease: Insights From Cardiovascular Magnetic Resonance and Positron Emission Tomography
Summary: The impairment of myocardial oxygenation during stress has not been traditionally described as part of the continuum of events that characterize the ischemic cascade. However, ischemia is classically defined as the mismatch between oxygen supply and demand at stress. We used positron emission tomography to measure regional myocardial perfusion (absolute myocardial blood flow) and cardiovascular magnetic resonance to assess regional myocardial oxygenation in patients with known coronary artery disease and normal volunteers. Our findings indicate that whereas conceptually, impairment of both perfusion and oxygenation occurs early in the ischemic cascade, it may not always occur simultaneously in coronary artery disease. We therefore speculate that the addition of oxygenation assessment using blood oxygen level-dependent cardiovascular magnetic resonance to the noninvasive imaging armamentarium will better identify functionally significant coronary stenoses. Finally, given the recent concerns over gadolinium contrast safety in patients with severe renal disease, the assessment of myocardial oxygenation with blood oxygen level-dependent cardiovascular magnetic resonance might be an attractive alternative to first-pass perfusion imaging in such patients.
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A 4-Tiered Classification of Left Ventricular Hypertrophy Based on Left Ventricular Geometry: The Dallas Heart Study
Summary: Left ventricular hypertrophy (LVH), defined as increased indexed LV mass, is presently classified based on the ratio of the LV wall thickness to chamber dimension. If this ratio is increased, then the LVH is concentric; otherwise the LVH is eccentric. We propose a 4-tiered classification based on whether or not LV concentricity 0.67 (LV mass/LV end-diastolic volume 0.67 [EDV] ) and LVEDV/body surface area are increased. Among 2803 subjects who underwent cardiac MRI, 895 had LVH. Of these, 361 had increased concentricity 0.67 but not LVEDV ("thick hypertrophy"), 53 had increased LVEDV but not concentricity 0.67 ("dilated hypertrophy"), 13 had both increased concentricity 0.67 and LVEDV ("both thick and dilated hypertrophy"), and 468 had neither increased concentricity 0.67 nor LVEDV ("indeterminate hypertrophy"). Subjects with both thick and dilated hypertrophy had a lower LV ejection fraction and higher natriuretic peptide levels versus those with isolated thick hypertrophy. Subjects with indeterminate hypertrophy had a higher LV ejection fraction and lower troponin T and natriuretic peptide levels versus those with dilated hypertrophy and no increase in troponin T or natriuretic peptide levels versus those without LVH. We conclude that concentric and eccentric LVH can each be subclassified into 2 distinct subgroups based on the presence of LV dilation. These data question whether LVH should be considered present only if there is increased LV mass and also increased LV wall thickness and/or ventricular dilation. Refinement of the phenotypic characterization of LVH may improve our understanding of its natural history and provide an opportunity for more specific and possibly earlier therapeutic intervention.
Conclusions: Concentric or eccentric LVH can each be subclassified into 2 subgroups, yielding 4 distinct geometric patterns. Many subjects currently classified with eccentric LVH can be reclassified into an indeterminate subgroup that has better LV function and comparable levels of biomarkers reflecting cardiac stress as compared with those without LVH. 87
Are Shades of Gray Prognostically Useful in Reporting Myocardial Perfusion Single-Photon Emission Computed Tomography?
Summary: Myocardial perfusion single-photon emission computed tomography (MPS) is one of the most commonly used cardiac imaging tests, yet the way it is reported is not uniform. Although semiquantitative analysis of the global perfusion deficit has been shown to be prognostically important, it is not universally used, and the implication of nonzero scores that fall below the threshold of abnormal is unclear. We sought to determine whether expression of the level of certainty regarding presence of abnormality (5-point score, from definitely normal to definitely abnormal) had prognostic value. Based on the analysis of the clinical and prognostic data of 18,200 patients who underwent rest-stress dual-isotope MPS, we demonstrated that the final level of clinical scan certainty is an independent multivariable predictor of cardiac death in the study population. The use of multicategory reporting of MPS results incorporating nonperfusion MPS results and clinical information enhances risk stratification in comparison to both a dichotomous normal/abnormal approach and an approach based solely on summed perfusion scores and results in a smaller group of patients whose scans are deemed to be equivocal. Myocardial dyssynchrony is also related to the development and progression of heart failure. Our goal was to study the relationship of LV mass and age with dyssynchrony in asymptomatic participants of the Multi-Ethnic Study of Atherosclerosis and to obtain more insight into the mechanisms underlying the development of myocardial dysfunction. A total of 1100 individuals underwent tagged MRI. Their regional LV function was analyzed with the use of time parameters of myocardial deformation including time to peak systolic strain and strain rate. Myocardial dyssynchrony was expressed by SD of time to peak strain and strain rate. There was a direct relationship between age and delayed time to peak strain and a greater extent of dyssynchrony. Importantly, there was also significant association between LV mass and time to peak strain, time to peak strain rate, and the SD of time to strain rate. In a subset of patients (n74), the relationship between myocardial perfusion and timing of contraction was studied. Decreased myocardial perfusion at rest was associated with delayed contraction and increased extent of dyssynchrony. These new data may enhance our understanding of the development of myocardial dysfunction and its possible prevention. We believe that myocardial dyssynchrony may explain, at least partly, the well-known association between aging and LV hypertrophy and LV dysfunction. This association may be mediated by changes in myocardial perfusion. However, the temporal relationships between aging, LV hypertrophy, reduced myocardial perfusion, dyssynchrony, and LV dysfunction should be clarified further.
Conclusions
Conclusions: In asymptomatic individuals, age, increased LV mass, and decreased myocardial perfusion are related to delayed myocardial contraction and greater extent of dyssynchrony. Increased dyssynchrony may mediate the association of myocardial dysfunction with age and LV hypertrophy. 89
Molecular Imaging of Atherosclerotic Plaques Targeted to Oxidized LDL Receptor LOX-1 by SPECT/CT and Magnetic Resonance
Summary: Oxidized low-density lipoprotein plays a critical role in atherosclerosis, and its effects are mediated by activation of its specialized receptor, LOX-1. LOX-1 induces apoptosis, expression of adhesion molecules and matrix metalloproteinases, and in general, activates inflammation. LOX-1 activation not only initiates lesion formation but also contributes to the vulnerability of the plaque to rupture. Thus, a noninvasive molecular imaging approach to identify LOX-1 in the live animal would be advantageous to study the atherosclerotic process early in its natural history to enable optimal therapies to prevent acute coronary syndromes. Imaging probes for both single-photon emission computed tomography/computed tomography and MRI were constructed that consisted of liposomes decorated with anti-LOX-1 antibodies (LOX-1 probe) and either 111 indium or gadolinium, as well as fluorescent markers. In vivo imaging was performed 24 hours after intravenous injection of 150 L LOX-1 probe in mouse models of atherosclerosis. Single-proton emission computed tomography/computed tomography imaging showed aortic arch hot spots, and MRI showed significant contrast enhancement in aortic atherosclerosis. Binding was shown to be specific for LOX-1, and the probe bound preferentially to the plaque shoulder, a region with vulnerable plaque features including extensive LOX-1 expression, macrophage accumulation, apoptosis, and matrix metalloproteinase-9 expression. Thus, this flexible multimodality molecular imaging approach could be used to identify features of vulnerable plaque in vulnerable patients. Moving this approach into the clinic to identify patients at risk for acute coronary syndromes could lead to improved targeting of therapies aimed at reducing inflammation and atherosclerosis to prevent these syndromes.
Conclusions: LOX-1 can be used as a target for molecular imaging of atherosclerotic plaque in vivo. Furthermore, the LOX-1 imaging signal is associated with markers of rupture-prone atherosclerotic plaque. 90
Strain-Encoded MRI for Evaluation of Left Ventricular Function and Transmurality in Acute Myocardial Infarction
Summary: Identification of the extent and degree of contractile dysfunction and myocardial scar in patients after acute myocardial infarction has important prognostic implications. In this study, we introduced strain-encoded imaging as a novel MR technique for myocardial deformation imaging that enables the quantification of regional deformation of tissue as a result of cardiac motion. We demonstrated that strain parameters obtained from strain-encoded MR imaging can be used to analyze regional contractile function and transmurality states in patients with acute myocardial infarction. As quantification of regional myocardial function becomes more and more important in clinical routine, strain-encoded imaging provides rapid and objective strain analysis, without the need for timeconsuming postprocessing.
Conclusions: Strain-encoded imaging provides rapid and objective quantification of regional myocardial function and allows discrimination between different transmurality states in patients with acute myocardial infarction. 91
In Vivo Quantification of Carotid Artery Wall Dimensions: 3.0-Tesla MRI versus B-Mode Ultrasound Imaging
Summary: Atherosclerosis imaging of the carotid arteries can be used to assess both cardiovascular disease risk as well as the efficacy of novel cardiovascular drugs. Presently, the B-mode ultrasound measurement of carotid intima-media thickness is the most widely available and best validated atherosclerosis imaging technique. Nonetheless, as atherosclerosis is a 3D, irregular, and eccentric disease process, longitudinal 2D ultrasound carotid intima-media thickness measurements of the arterial wall have their inherent limitations. We set out to compare high-resolution B-mode ultrasound carotid intima-media thickness with carotid 3.0-T MRI measurements in humans. We observed that both MRI and ultrasound measurements provide similar results in terms of carotid arterial wall thickness. MRI, however, showed a much better reproducibility than ultrasound. The 3D, highly reproducible MRI may provide a better surrogate for the evaluation of the efficacy of antiatherosclerotic drugs.
Conclusions:
The study data for carotid MRI and ultrasound intima-media thickness showed strong agreement, indicating that both modalities measure the thickness of the intima and media. The advantage of MRI over ultrasound is that the measurement variability is smaller, enabling smaller sample sizes and potentially shorter study duration in cardiovascular prevention trials. 92
Alteration in Left Ventricular Strains and Torsional Mechanics After Ultralong Duration Exercise in Athletes
Summary: Ultralong-duration exercise may cause myocardial damage associated with transient systolic and diastolic dysfunction. To get insight into the underlying mechanisms responsible for the observed decrease in left ventricular (LV) function, we used 2D ultrasound speckle tracking imaging and assessed LV regional strain and torsion during the cardiac cycle. During systole, we observed a decrease in LV longitudinal, circumferential, and radial strain. The reduced myocardial peak systolic strain rates reflected alterations in myocardial contractility that contributed to the reduced ejection fraction and stroke volume after the race. During diastole, LV twist was decreased and delayed. This was associated with a loss of the rapid untwisting that occurs during isovolumic relaxation, a key factor of LV diastolic suction and thus of early filling. Similar myocardial deformation abnormalities have been demonstrated in patients with chronic LV overload due to aortic regurgitation. Torsional mechanical alterations similar to those found in our athletes after ultralong exercise have also been documented in states associated with worsened relaxation such as chronic pressure overload or tachycardia-induced dilated cardiomyopathy. Although previous studies have documented that the LV dysfunction observed after endurance exercise resolves within 1 week, the time course of recovery of LV strain and torsion remains to be explored. Moreover, the long-term consequences of the transient myocardial insults and functional abnormalities that occur after repetitive prolonged exercise are unknown and represent an important issue for future investigation.
Conclusions: This study documented major alterations in cardiac strains and torsion after an ultralong distance triathlon. LV systolic strains were depressed but not delayed, whereas twisting was decreased and delayed. This altered pattern hampered the rapid untwisting during isovolumic relaxation phase, reducing LV diastolic suction and early filling. 93
Features of Carcinoid Heart Disease Identified by 2-and 3-Dimensional Echocardiography and Cardiac MRI
Summary: Carcinoid heart disease is a common complication and a major cause of morbidity in patients with carcinoid syndrome. The classic echocardiographic features of tricuspid and pulmonary valvular dysfunction are well recognized. The role of newer imaging modalities including 3D echocardiography and cardiac MRI has been not been established. The current study prospectively assessed a large cohort of patients with carcinoid syndrome for features of carcinoid heart disease using a variety of imaging modalities, including both 2D and 3D transthoracic and transesophageal echocardiography as well as cardiac MRI. A spectrum of disease from early to advanced disease was identified. The extent and severity to which each valve leaflet or cusp and its associated subvalvular apparatus was affected was highly variable, producing a wide range of appearances. Three-dimensional transthoracic and transesophageal echocardiography are particularly useful in identifying pathology in the pulmonary and tricuspid valve, as all leaflets may not be visualized on 2D echocardiography. Cardiac MRI allowed quantification of the size of cardiac metastases and the extent of their invasion into the myocardium. Positron emission tomography imaging allowed functional assessment of metastases. The study recommends an integrated approach using multiple modalities in patients at risk of carcinoid heart disease to identify pathology and assess severity of disease.
Conclusions: Carcinoid heart disease is a heterogeneous disease with a wide spectrum of echocardiographic findings. A multimodality approach is needed in patients with this complex pathology. 94
Incremental Prognostic Value of Myocardial Perfusion Imaging in Patients Referred to Stress Single-Photon Emission Computed Tomography With Renal Dysfunction
Summary: Coronary artery disease is the main cause of mortality and morbidity in patients with impaired renal function, a population that is rapidly growing in the United States. In a cohort of 7348 consecutive patients with various degrees of renal impairment, we evaluated the prognostic implications of single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI). Our analysis shows that at each stage of impaired renal function, patients with abnormal SPECT-MPI had increased hazards of adverse events (PϽ0.0001). Patients with stage IV kidney disease and perfusion defect have the highest risk of all-cause mortality. In multivariable analysis, the magnitude of total perfusion deficit and ischemia on MPI were associated with worse outcome after adjusting for confounding variables including glomerular filtration rate and ejection fraction. Although the decline of renal function is associated with increased all-cause mortality, SPECT-MPI adds modest incremental prognostic information to identify patients at higher relative risk of death across the spectrum of renal function. Future research is warranted to investigate whether invasive and pharmacological tools to reduce the degree of ischemia in these patients would alter their outcomes.
Conclusions: SPECT-MPI adds modest incremental prognostic information to identify patients at higher relative risk of death across a wide spectrum of renal function. 96
In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in Rodents: Differential Efficacy of Metformin and Rosiglitazone Monotherapy
Summary: Cardiovascular disease is the leading cause of death among diabetic patients. There is increasing evidence suggesting that diabetic patients have a predisposition to heart failure resulting from impairment in heart muscle contraction, particularly abnormalities in diastolic function. One hypothesis argues that the observed abnormalities in diastolic function are a consequence of alterations in myocardial substrate metabolism such that the diabetic heart relies more on fatty acid metabolism than glucose metabolism to meet its energy needs. Increased reliance on fatty acids leads to accumulation of fatty acid intermediates as well as triglycerides resulting in lipotoxicity of the heart. In this work, we validated technology to noninvasively assess alterations in myocardial substrate metabolism, allowing observation of metabolic alterations in vivo potentially preceding development of abnormalities in diastolic function. Moreover, as treatment strategies aim to restore a level of glycemic control, the methodology allows for noninvasive monitoring of therapeutic efficacy, as we have demonstrated in this work.
Conclusions: Treatment with rosiglitazone enhanced glucose utilization and diminished MFAO, thus reversing the metabolic phenotype of the diabetic heart. 97
Strain-Encoded Cardiac MRI as an Adjunct for Dobutamine Stress Testing: Incremental Value to Conventional Wall Motion Analysis
Summary: The assessment of inducible regional wall motion abnormalities during high-dose dobutamine stress MRI is an established clinical method for the evaluation of patients with coronary artery disease (CAD). However, the assessment of cine images relies on subjective interpretation of regional wall motion, and objective approaches for the detection of inducible ischemia with dobutamine stress MRI are lacking. We used strain-encoded MRI for the objective color-coded evaluation of regional myocardial strain during dobutamine stress MRI in a cohort of subjects with suspected or known CAD (nϭ101). Strain-encoded MRI yielded significantly higher sensitivity than visual wall motion analysis (85% versus 70%, respectively; PϽ0.01) for detection of obstructive CAD as assessed by coronary angiography. In addition, strain-encoded MRI identified significant CAD in 8 subjects that were missed by visual wall motion analysis (PϽ0.05). Quantification analysis demonstrated that impaired strain rate response during dobutamine stress MRI is a highly sensitive marker of inducible ischemia, which seems to occur earlier in the ischemic cascade than wall motion abnormalities. The increased sensitivity of strain-encoded MRI may help with the evaluation of patients with known or suspected CAD.
Conclusions:
The direct color-coded visualization of strain on MR images is a useful adjunct for dobutamine stress MRI, which provides incremental value for the detection of CAD compared with conventional wall motion readings on cine images. 98
In Vivo Measurement of Mitral Leaflet Surface Area and Subvalvular Geometry in Patients With Asymmetrical Septal Hypertrophy: Insights Into the Mechanism of Outflow Tract Obstruction
Summary: Dynamic left ventricular outflow tract obstruction (LVOTO) has long been recognized as a central feature of hypertrophic cardiomyopathy. Analyzing the determinants of systolic anterior motion of the mitral valve and consequent LVOTO in patients with asymmetrical septal hypertrophy requires a comprehensive 3-dimensional analysis of mitral leaflet area, papillary muscle (PM) geometry, and distribution of left ventricular hypertrophy. This study used real-time 3-dimensional echocardiography to demonstrate that patients with asymmetrical septal hypertrophy and LVOTO have larger mitral leaflet areas and shorter inter-PM distance. Determinants of minimal LVOT area during systole were end-systolic volume, indexed total mitral leaflet area, inter-PM distance, annular height, and LVOT hypertrophy index. These findings support the concept that myocardium is not the only tissue affected in patients with asymmetrical septal hypertrophy, and integrated PM-mitral valve geometry best explains the pathogenesis of LVOTO in patients with asymmetrical septal hypertrophy, with increased mitral leaflet area and annular height allowing greater leaflet slack, and PM position and LVOT hypertrophy positioning the slack leaflet into left ventricular outflow. Because each element of PM-mitral valve geometry can be thoroughly evaluated with the use of real-time 3-dimensional echocardiography, an individualized strategy can be applied accordingly, and primary changes of the mitral leaflet and subvalvular apparatus can be potential targets of new treatment options for effective relief of LVOTO.
Conclusions: Myocardium is not the only tissue affected in patients with asymmetrical septal hypertrophy, and primary changes of the mitral apparatus, including ML area increase and PM displacement, are independent determinants of LVOT obstruction and provide a comprehensive mechanism that determines leaflet slack and anteriorly directed motion. Abnormal PM-mitral valve geometry assessed by real-time 3-dimensional echocardiography can provide reasonable new targets for individualized intervention. 99
Sequential Changes of Myocardial Microstructure in Patients Postmyocardial Infarction by Diffusion-Tensor Cardiac MR: Correlation With Left Ventricular Structure and Function
Summary: Postinfarction late remodeling involves the left ventricle globally and is associated with time-dependent dilatation, distortion of ventricular shape, rearrangement of fiber architecture, and mural hypertrophy. Clearly, there is a great need for, and utility in, the in vivo acquisition of a wealth of cardiac microstructures, such as geometry, fiber and sheet orientation, and cell populations, to improve our ability to design strategies for effective restoration of myocardium postinfarction. This study investigated the sequential changes of myocardial microstructure from recent myocardial infarction to chronic myocardial infarction and correlated it with the sequential changes of the left ventricular wall thickness and thickening. Wall thickness and wall thickening decreased sequentially in the infarct-adjacent zone and increased in the remote zone. In microstructure, there was improvement of tissue integrity, reflected by decreased mean diffusivity. This improvement was found to be associated with the improvement of the thickening of the local wall. Fiber architecture adaptation showed more right-handed helical reorientation (increased subendocardial fiber proportion) and was correlated with improvement of the thickening of the remote wall. The observed interplay between myocardial microstructure and the left ventricular wall structure and function may shed light on the biomechanics behind the process of postinfarction remodeling and might be helpful in the management involving restoration of normal scaffold of fiber architecture in myocardium postinfarction.
Conclusion: Diffusion-tensor cardiac MR suggests that sequential zonal improvement of tissue integrity and fiber architecture remodeling both associate with sequential recovery of zonal wall thickening of the left ventricle from recent to chronic MI. 100
Maladaptive Aortic Properties in Children After Palliation of Hypoplastic Left Heart Syndrome Assessed by Cardiovascular Magnetic Resonance Imaging
Summary: In children with hypoplastic left heart syndrome, the status of the reconstructed aorta after the Norwood operation is of potential prognostic importance. Dilatation and an impaired distensibility of the neoaorta have already been reported in previous echocardiographic and angiocardiographic studies. However, comprehensive data on the anatomic and functional properties of the reconstructed aorta and their potential influence on right ventricular function in hypoplastic left heart syndrome are still lacking. The present study used cardiovascular MRI to evaluate the anatomy, bioelastic properties, viability of the aorta and right ventricular ejection fraction in 40 patients with hypoplastic left heart syndrome. Compared with control subjects, patients with hypoplastic left heart syndrome had an increased aortic size and reduced aortic bioelasticity (distensibility and pulse-wave velocity). Fibrosis was detected with cardiovascular MRI in the proximal aorta using the well-proven late gadolinium enhancement technique. Aortic late gadolinium enhancement correlated inversely with reduced right ventricular ejection fraction and distensibility in the ascending aorta. These findings suggest unfavorable aortic-ventricular coupling, which may contribute to a higher risk for later right ventricular failure. This study may help improve our understanding of aortic biophysical properties after extensive surgical reconstruction of the aorta. The results may serve as baseline data for further longitudinal studies in children with hypoplastic left heart syndrome to establish the prognostic value of anatomic and bioelastic aortic properties measured by cardiovascular MRI.
Conclusions: Adverse aortic properties post palliation of hypoplastic left heart syndrome manifest themselves by aortic dilatation, decreased distensibility, and increased volume of nonviable aortic wall tissue. The negative association between aortic late gadolinium enhancement and right ventricular ejection fraction suggests unfavorable aortic-ventricular coupling. The potential impact of these findings on long-term right ventricular function should be evaluated in future studies. 101
In Vivo Therapeutic Gas Delivery for Neuroprotection With Echogenic Liposomes
Summary: Stroke is the third leading cause of death and the most common cause of adult disabilities in the United States. The emergent treatment of acute ischemic stroke has 2 primary goals: rapid restoration of cerebral blood flow (reperfusion) and limitation of neural injury (neuroprotection). Although many therapeutic strategies have demonstrated pharmacological effect for neuroprotection including their ability to decrease stroke size, these strategies often fail when translated to the clinical setting. Inability to deliver high local doses sufficiently to the ischemic area and inadequate penetration of therapeutic agents across the blood-brain barrier are major contributory factors. The present study suggests that intravenous delivery of a noble gas, xenon, which readily diffuses across the blood-brain barrier, with the use of a delivery vehicle (liposomes) and a release mechanism (ultrasound), enhances local xenon delivery and decreases stroke size. Site-specific payload release from liposomes can be controlled by low-power ultrasound over the common carotid artery with enhanced neuroprotective delivery to the ischemic circulation. This study demonstrates that both intra-arterial and intravenous carrier deliveries with low-power ultrasound activation over the common carotid artery have the same therapeutic effect for neuroprotectant payload delivery to the cerebral ischemic area. Together, this novel delivery vehicle and delivery methodology have the potential to provide a clinically effective and efficient means for therapeutic gas/pharmaceutical delivery for improved stroke treatment.
Conclusions: This novel methodology may provide a noninvasive strategy for ultrasound-enhanced local therapeutic gas delivery for cerebral ischemia-related injury while minimizing systemic side effects. 102 
